Regulation of pteridine biosynthesis by Shivvers, Douglas Wesley
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
1971
Regulation of pteridine biosynthesis
Douglas Wesley Shivvers
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
Part of the Microbiology Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Shivvers, Douglas Wesley, "Regulation of pteridine biosynthesis " (1971). Retrospective Theses and Dissertations. 4583.
https://lib.dr.iastate.edu/rtd/4583
72-12,594 
SHIWERSj Douglas Wesley, 1939-
REGULATION OF PTERIDINE BIOSYNTHESIS. 
Iowa State University, Ph.D., 1971 
Bacteriology 
University Microfilms, A XEROX Company, Ann Arbor, Michigan 
THIS DISSERTATION HAS BEEN MICROFILMED EXACTLY AS RECEIVED 
Regulation of pteridine "biosynthesis 
by 
Douglas Wesley Shi we r s 
A Dissertation Submitted to the 
Graduate Faculty in Partial Fulfillment of 
The Eequirements for the Degree of 
DOCTOR OF PHILOSOPHY 
Major subject: Bacteriology 
Approved; 
In Charge of Major Work 
For the Major Department 
For the Graduate College 
Iowa State University 
Ames, Iowa 
1971 
Signature was redacted for privacy.
Signature was redacted for privacy.
Signature was redacted for privacy.
PLEASE NOTE: 
Some pages have indistinct 

























Pardee (8l) suggests that a hacterium contains three groups of 
enzymes based upon the rate at vhich the substrate is used. •The first 
group of enzymes catabolizes a primary carbon source at the rate of 10^ 
molecules of substrate per minute per cell. The second group of enzymes 
synthesizes the major cell metabolites, amino acids, purines and 
pyrimidines, and uses 10^ molecules of substrate per minute per cell. The 
last group of enzymes synthesizes the minor constituents, vitamins and 
coenzymes, and uses 10^ molecules of substrate per minute per cell. Thus, 
the rate of vitamin synthesis is 1000 times less than the rate of amino 
acid synthesis (63). 
The regulation of the enzymes in the first two groups is defined in 
terms of constitutivity (20, ^ 5)> induction-repression (21, U5) and nega­
tive feedback inhibition (53» 113» 13l). The constitutive en^mes are 
produced at a relatively constant rate independent of nutritional condi­
tions and the enzyme concentration varies no more than 5-fold (82 )• In 
contrast to the constitutive enzymes, the enzymes subject to induction-
repression are synthesized at different rates depending upon the nutri­
tional conditions. The rate of enzyme formation may vai-y by at least 
10-fold (2, 9, 130) and some rates of enzyme formation can vary by a 
factor of 1000 or more (19, 38, 99). Finally, for enzymes subject to 
negative feedback inhibition, the activity of an enzyme can be decreased or 
inhibited by a product of the biosynthetic pathway in which the enzyme 
functions, thereby maintaining a constant intracellular level of product. 
The regulation of the enzymes in the third group, those responsible 
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for the synthesis of the minor constituents, is poorly understood. Pardee 
and co-workers (81, 82, 125) state that there is no reason to believe that 
the control mechanisms for all enzymes are similiar and imply that an 
elaborate control mechanism for the minor pathways might not be economical. 
Therefore, the enzymes of the minor pathways are probably produced at a 
steady rate slightly greater than is essential for growth (constitutivity). 
Since several vitamin reactions are carried out at high velocities, nearly 
equal to the velocity of the glycolytic enzymes, the overall rate of vitamin 
synthesis is presumably limited by the number of enzymes, one or a few 
enzyme molecules per cell (63). Thus, the regulation of vitamin biosynthe­
sis is closely linked to the regulation of enzyme synthesis. Repression 
is suggested as the mechanism which maintains the low levels of the flavin 
biosynthetic enzymes (95, 125)• However, only nicotinic acid mononucleo­
tide pyrophosphorylase (38) and the enzyme which synthesizes biotin from 
desthiobiotin (78, 79» 80) are known to be subject to induction-repression. 
It is questioned whether negative feedback inhibition plays a significant 
role in the regulation of vitamin biosynthesis (8I, 82, 125). There have 
been direct but unsuccessful searches for negative feedback inhibition 
using the known enzymes responsible for pyridine nucleotide coenzyme 
biosynthesis (38) and the initial enzyme in pteridine biosynthesis, GTP-
cyclohydrolase (18, T. Shiota, University of Alabama Medical Center, 
Birmingham, personal communication). The only evidence for negative feed­
back inhibition is the strong inhibition of dihydroneopterin aldolase, an 
enzyme in the folic acid pathway, by its immediate product, 2-amino-U-
hydroxy-6-hydroxymethyIdihydropteridine, and weak inhibition by dihydro-
pteroic and dihydrofolic acids (62). It is probable that other vitamin 
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biosynthetic enzymes are also subject to feedback inhibition, but since so 
few vitamin enzymes are known, either the wrong enzymes or the wrong 
affectors have been used in attempts to demonstrate feedback inhibition. 
There is so little known about the biosynthetic pathways of the minor 
metabolites that it is not too surprising that the regulation of these 
pathways is not understood. The terminal enzymatic reactions are known 
for most vitamin pathways, but the substrate and the initial enzymatic 
reactions are unlinoim for all but the folic acid and possibly the ribo­
flavin pathways. The following are some reasons why so little is knoim 
about the biosynthesis of the minor metabolites : the vitamins are synthe­
sized at a low rate, about 1 nmole per mg dry wei^t of organisms per hour 
compared to 1 to 3 ymoles for the amino acids (63, 6U, 65, 66, 67); the 
substrates are unknown; the intermediates are unknown; the intermediates 
are synthesized in extremely small quantity; the intermediates are usually 
transitory and the suspected intermediates are not commercially available. 
The folic acid pathway is the best defined pathway of the minor 
metabolites. Zven so, only three enzymes of the folate pathway are known. 
The enzymes are large conglexes (I8, 62) and two are known to catalyze 
more than one reaction. Still, no mechanism has been proposed for the 
regulation of the folate pathway. 
It has been shown (IO8 ) that GTP-cyclohydrolase is the first enzyme 
in the biosynthesis of pteridines and folic acid-like compounds in. 
StaphyZocoacus epi-dermidis» The initial reaction opens the imidazole ring 
of guanosine-5'-triphosphate -(GTP) and eliminates carbon atom-8 as formic 
acid. A similar purine ring-opening mechanism has been reported in the 
biosynthesis of riboflavin (35, 68, TO ), toxiflavin (56 , 57 , 58 ), 
pyrroiopyrimidine nucleosides (112) and unconjugated pteridines (33), as 
well as folic acid-like compounds (17, l8, 102, 108). %en more than one 
of these biosynthetic pathways is present in an organism, there must be 
more than one mechanism to remove C-8 of purines or a "branched "biosynthetic 
pathway with a common precursor and probably some common intermediates. 
Since both riboflavin and folic acid-like compounds are synthesized by 
S, epi-dermidis, it is possible that the two pathways share a common 
• precursor and the two pathways have some common intermediate compounds. 
If this is true, then the regulation of the early steps of folic acid 
biosynthesis can not be adequately described without also describing the 
regulation of riboflavin biosynthesis. 
At the initiation of this study, the knowledge of folate biosynthesis 
in 5. epzdermidi-s was limited to the biosynthetic pathway and the types of 
natural products synthesized (10, UO, 71, 108, 123, 124). Very little was 
known about when or how much vitamin was synthesized or if the quantity 
varied with physiological changes. Essentially nothing was known about 
riboflavin biosynthesis in S, epi-dermz-dis. 
The approach that I have used to examine the regulation of pteridine 
biosynthesis is: first, to examine how folic acid and riboflavin biosyn-
theses change in response to the physiological changes that occur during 
growth and in different culture media; second, to examine the variation in 
specific activity of enzymes from the pteridine pathway, the folic acid 
pathway and the riboflavin pathway in response to physiological changes; 
and third, to provide evidence that the folic acid and the riboflavin 
pathways are related. 
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LITERATURE REVIEW 
The isolation and identification (29» 55), chemistry (83) and "biology 
(116) of pteridines have been reviewed. Reviews of the pteridine cofactors 
have been restricted largely to folic acid (li3, 87» 109)> recently the 
unconjugated pteridine cofactors have been emphasized (28, %%). 
The pteridine ring system consists of fused pyrimidine and pyrazine 
rings (pyrimido-[4,5—b]-pyrazine). The naturally-occurring pteridines 
have an amino and a hydroxy substitution on the 2 and 4 positions 
respectively. The 2—amino-!t-hydroxypteridine derivative has been assigned 
the tri val name of 'pterin' and the 2,li-dihydroxypteridine derivative has 
been assigned the tri val name of 'lumazine'. Of the nine possible tauto­
meric forms for pterins, only 2-amino-3,U-dihydro-U-ketopteridine predomi­
nates in aqueous solution (l4, 84 ). 
The pteridines have been subdivided into conjugated and unconjugated 
classes. The conjugated pteridines are the pteroic acid-like and the 
folic acid-like compounds. All other pteridines are classed as unconju­
gated pteridines (U7). 
Purine precursors of pteridines and riboflavin 
Because of the structural resemblance and the incorporation of radio­
active formate and glycine into analogous portions of purines, pteridines 
and the isoalloxizine ring of riboflavin (11, I6, 31, 85 » 86 )» & biological 
precursor-product relationship was suspected for some time. 
Weygand and Valdschmidt CL21 ) provided evidence that the biosynthetic 
pathways of purines and pteridines were closely related. Since then, 
evidence has accumulated that shows purines can be precursors of pteridines 
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(1, 11, 12, 115; 122, 132). Vieira and Shaw (II5) established that radio­
activity from adenine-2-l^C but not adenine-8-^^C was incorporated into 
pterc^ltriglutamic acid (teropterin) in whole cells of CorynebacteTiian sp. 
Reynolds and Brown (92, 93) demonstrated in cell-free extracts of 
Eaaheridhia cdli. that pteridines were synthesized from guanosine, guanosine 
nucleotides or guanine and 5-phosphoribosyl-l-pyrophosphate. Wo other 
purine compounds formed pteridines which would react with p-amLnobenzoyl-
glutamate to yield folic acid. Guanosine-5'-triphosphate (GTP) was shown 
to be a precursor of pteridines in cell-free extracts of Comamonas sp. (23), 
coVi (18, Ul, 42), Lastobas-illus plcmtcanan (102), Fseudomonas cocovenans 
(56, 57» 58), Fseudomonas sp. (33), SdLwoneVla typhimur-ùwn i2h) and 
5. epi-dermidf s (108), 
Adenine, guanine, xanthine and hypoxanthine were shown to stimulate 
riboflavin productiœ. in cultures of Eremotheoivm ashoyvL (60) and in 
Sacohcapomyces cevevis-iae (30). McNutt (68, 69) demonstrated in cultures of 
E, ashbylv that radioactive swienine was incorporated into riboflavin. 
Furthermore, the nucleic acid bases stimulated riboflavin synthesis to a 
greater extent than the nucleoside or nucleotide with the exception of 
guanine-5'-monophosphate (GMP). By using a double labeled purine, xanthine-
McNutt (70) unequivocally demonstrated the direct incorporation of 
the diamino-pyrimidine moiety remaining after the loss of C-8 into ribo­
flavin. Bacher and Lingens ( k) used a polyauxotrophic mutant of Aerobaater 
aerogenes with a genetic block in the purine pathway prior to inosine-5 
monophosphate (IMP) and a genetic block between xanthosine-5'-monophosphate 
(XMP) and GI4P. Xanthine-2-^^C was incorporated into xanthosine but not 
riboflavin while guanine-2-l^C was incorporated into riboflavin without 
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significant dilution. Both adenosine-^'-monophosphate (AMP) and IMP were 
excluded as precursors of riboflavin since there was no significant 
isotope dilution in the presence of unlabeled adenine or hypoxanthine. 
They concluded that a guanine derivative was the precursor of riboflavin. 
Baugh and Krumdieck (7) reached the same conclusion using decoyinine which 
blocks the conversion of XMP to GMP and a mutant of Copynebaaterium sp. 
which could not convert either xanthine or guanine to adenine. Guanine was 
also shown to serve as a precursor of riboflavin in E, ashbyii (35) and 
E, coVi (37). Since all of the precursor studies used whole cells, it was 
impossible to determine if guanine or a nucleoside or nucleotide derivative 
of guanine was the true precursor. 
Pteridine biosynthesis 
The initial reactions in pteridine biosynthesis which results in the 
release of C-8 of GTP as formic acid have been well documented (17, l8, 23, 
33» 56, 57» 58* 102, 108). The enzyme which catalyzes these reactions was 
nassd GTP-cyclohydrolase (I8) and was shown to have a molecular weight in 
exc-.rss of 200,000 (I8, T.Shiota, University of Alabama Medical Center, 
Birmingham» personal communication). Burg and Brown (18) used a highly 
purified preparation of GTP-cycldhydrolase from E. ooZi, to show that the 
other product of the purine ring-opening reaction was a triphosphate ester 
of 2-aiEino-U-hydroxy-6-(D-e2^tZtTO-l* ,2',3'-trihydroxyproiyl)-7*8-dihydro-
neqpterin (diiydroneopterin triphosphate). But, Cone and Guroff (23) 
reported that in cell-free extracts of Comamonas sp. the product was a 
cyclic phosphate ester of dihy drone opte rin. 
The ribose moiety of GTP was shown to be incorporated into pteridines 
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(52, 93) with carbon atoms 6, 7 and 9 of the pteridine originating from 
carbon atoms 2', 1' and 3' of ribose. Therefore, it was presumed that the 
ribose moiety of GTP was isomerized by an Amadori rearrangement. The Amadori 
rearrangement isomerizes an amino sugar to a l-amino-l-deoxy-2-keto 
derivative of the sugar (36). GTP-cyclohydrolase was indirectly shown to 
catalyze the Amadori rearrangement of the ribose moiety by using 7-methyl-
GTP, an analogue of GTP (129). The methyl group on ÏÏ-7 of GTP does not 
inhibit the purine ring-opening reaction but does prevent the pteridine 
ring closure. The Amadori rearrangement product was identified by the ease 
with which it reacted with phenylhydrazine to give a ribose phenylosazone. 
It is interesting that C-8 of 7-methyl-GTP wais not released as formic acid, 
suggesting that the Amadori rearrangement occurred after the purine ring 
cleavage but before the elimination of C-8 as formic acid. The Amadori 
rearrangement product is presumably a transitory intermediate which reacts 
immediately to yield dihydroneopterin triphosphate. A chemical model 
system indicated that the pteridine ring closure was nonenzymatic (110). 
No biological intermediates between GTP and neopterin have been 
directly isolated or identified. The hypothetical intermediates should be 
derivatives of 2,U,5-triamino-6-hydroxypyrimidine with a phosphate ester of 
either ribose or a l-deoxy-2-keto pentose unit substituted onto N-lt. Some 
intermediates may also have a formyl group substituted onto the N-5 
position. 2-Amino-U-(5'-triphosphoribosyl)amino-5-formamido-6-hydroxy-
pyrimidine was chemically prepared from GTP and implicated as an intermedi­
ate in pteridine synthesis since it acted as a substrate for, the enzymatic 
release of formic acid and the synthesis of dihydrofolate in extracts of 
L» "ptantœnm (103, 107). The lt,5-diaminojyrimidine derivatives were 
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further irçlicated as intermediates when Leveaherg and Kaczmareh (57) 
condensed the resulting U,5-diaminopyrinidines, enzyraatically derived 
from GTP, with glyoxal and identified the pteridine derivatives which were 
formed. Both pterin and lumazine derivatives were found which indicated 
that the 2-amino substituent of GT? must have heen oxidatively deaminated. 
The GIP-cyclohydrolase molecule is large and seems to catalyze the 
following reactions in the synthesis of dihydroneopterin triphosphate: two 
hydrolytic reactions in the release of C-8 of GTP as formic acid; the 
isomsrization of the ribose moiety to a l-deoxy-2-keto pentose unit; and 
possibly the oxidative deamination of the pyrimidine intermediates. 
Jones and Brown (bl, 42) demonstrated that dihydroneopterin was 
enzymatically converted to 2-amino-3:-hydroxy-6-hydroxymethyl-7,8-dihydro-
pteridine (hydroxymethyldihydropteridine) with the loss of a two-carbon 
unit. I4athis and Brown (62) used a purified enzyme from E, coZi- and 
identified the two-carbon compound as glycoaldehyde. The enzyme, dihydro­
neopterin aldolase, was shown to have a molecular weight of 100,000 and to 
be heat stable. The enzyme was shown to be specific for dihydroneopterin. 
Heopterin, tetrahydroneopterin or phosphate esters of dihydroneopterin 
could not be used as substrate for the enzyme. The enzyme was strongly 
inhibited by the product of the reaction, hydroxymethyldihydropteridine, 
and weakly inhibited by dihydropteroic acid and dihydrofolic acid. 
Pteroic acid and folic acid biosynthesis 
Pteroic acid-like and folic acid-like cos^sounds are synthesized by 
enzymatically coupling a pteridine by a methylene bridge at C-6 with the 
amino group of either p-aminobenzoic acid (pABA) or p-aminobenzpylglutamic 
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acid (pABG) (lO, 15, ^ 0, 100, 101, 104, 105, 106, 120, 123, 12li). The 
following pteridine compounds in the presence of adenosine-5'-triphosphate 
(ATP) can serve as substrate for the biosynthesis of conjugated pteridines; 
2-amino-4-hydro%y-6-pteridine aldehyde (15» 5^» 100); 2-amino-6-
dihydroxypteridine (It6, 50); 2-amino-4-hydroxy-6-hydrozymethylpteridine 
(15, 100); 2-amino-U-hydrox3r-6-hydroxymethyldihydropteridine (10, 15, 39, 
^0, 71» 101); the monophosphate ester of hydroxymethyldihydropteridine 
(101, lOlt); and dihydroneopterin (!fl, k2^ 73). In the absence of ATP, the 
pyrophosphate ester of hydroxymethyldihydropteridine (liO, 77, 105, I06, 
120) and dihydroneopterin triphosphate (18) vere shown to be substrates in 
the synthesis of conjugated pteridines. Of the substrates examined in 
various bacterial extracts, hydroxymethyldihydropteridine pyrophosphate 
in the absence of ATP was shown to be the most active. The product of 
the reaction is either dihydropteroic acid (77, 105» I06, 120) or 
dihydropteroic phosphate (10, %0). 
The enzyme which catalyzes the coupling reaction, dihydropteroate 
synthetase, apparently has little specificity for substrate or can 
catalyze several reactions. It has been shown that dihydropteroate 
synthetase can add a pyrophosphate moiety to hydroxymethyldihydropteridine 
to form hydroxymethylpteridine pyrophosphate (^tO, 72) as well as to couple 
pABA with the pteridine substrate. Then in the presence of ATP, and 
glutamate, dihydropteroic acid can be enzymatically converted to dihydro-
folic acid by extracts of B, coti (32). In contrast, dihydrofolic acid 
has not been reported as a natural product in S, epidermidis, Instead, the 
products in S, ep-idemridi-s seem to be pteroic acid-like compounds (10, Uo, 
71, 123, I2U). 
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Riboflavin biosynthesis 
Guanine or a guanine nucleoside- or nucleotide-derivative has been 
established as the purine precursor for riboflavin biosynthesis (!<, 7, 35, 
37)* McNutt (69» 70) demonstrated that the four nitrogen atoms and C-4 of 
purines but not C-8 were incorporated into riboflavin by cultures of E. 
aéhbyii, Hayes and Greenberg (35) used guanine-8-^^C and showed that C-8 
of guanine was removed as a one carbon unit in cultures of E, ashbyii. 
Biey reported that 1Q% of the radioactivity from C-8 of guanine was found 
as free formic acid, 2Q% was found in protein, 10^ was incorporated into 
riboflavin and traces of radioactivity were found as free acetic acid. The 
radioactivity from guanine-2-^^C was incorporated into riboflavin. 
The mechanism by which purines are converted to riboflavin has not 
been shown, but the U,5-diaminopyrimidine compounds were implicated as 
intermediates since 6,7-dimethyl-8-( 1 '-D-ribityl)lumazine (dimethylribity 1-
lumazine), a known precursor of riboflavin (34, 88, 94, 117, 126), was 
chemically synthesized by a condensation of diacetyl with 4-(l'-D-rlbityl-
emino)-5-amino-2,6-dihydro%ypyrimidine (61, 88, 89, 117). Both 2,5-diamino-
6-bydroxy-4-(l'-D-ribitylaniino)pyrimidine (3, 5, 6, 76) and 5-amino-2,6-
dihydroxy-U-(l*—D-ribitylamino)pyrimidine (76, 98) were accumulated by 
riboflavinless mutants of Saooliarorryces aerevisiae (3, 5, 6, 76) and 
AspergitVus n'iduZans (98) which further in^licated the 4,5-diaminopyrimidine 
compounds as intermediates in riboflavin biosynthesis. Although these 
compounds were claimed to have been identified, only Bacher and Lingens 
(5) and Sadique et at» (98) provided any experimental data to characterize 
the nature of the compounds that accumulated. Neither the origin of the 
ribityl moiety nor the identification of the four-carbon compound which 
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condenses with the pyrimidine to form dimethylribityllumazine are known. 
Riboflavin synthetase, the terminal enzyme in the riboflavin pathway, 
vas characterized from extracts of Ashbya gossypi-i. and bakers yeast (88). 
Winestock et at, (126) established that dimethylribityllumazine was the 
substrate for the enzyme riboflavin synthetase. Plaut (68) clearly es­
tablished that two molecules of dimethylribityllumazine were consumed 
yielding one molecule of riboflavin, Plaut proposed that a four-carbon 
unit from one molecule of dimethylribityllumazine was donated to another 
molecule of dimethylribityllumazine to make riboflavin. The other product 
of this reaction was identified as 1*-( 1 '-D-ribitylamino)-5-amino-2,6-
dihydroxypyrimidine (117). Rowan and Wood (9^) proposed a nucleophillic 
ring-opening of the dimethylribityllumazine followed by an aldol condensa­
tion as the mechanism by which a four-carbon unit is transfered from one 
molecule of dimethylribityllumazine to another. 
• Although the enzymology of riboflavin biosynthesis is still unclear, 
there is a considerable amount of information about flavin synthesis in 
growing cultures. Flavins were reported to be synthesized at a constant 
rate in excess of that required for growth in cultures of E, coti. (125), 
A» gossxj-pvi (44) and Candida gui.lZ'iermondi.i. (95). There was no correlation 
between flavin synthesis and the supplimentation of the culture medium 
with a substrate that could be oxidized by flavoproteins (95). However, 
an iron-deficient medium inhibits growth but increases the rate of flavin 
synthesis (97). The rate of flavin synthesis was then inhibited by the 
addition of iron to the medium without any active multiplication of the 
cells. Kaplan and Demain (44) reported that growth temperature was 
ingortant to riboflavin biosynthesis since A» gossypii- synthesizes large 
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quantities of riboflavin at 28 C "but a ten^erature of 37 C was inhibitory 
to flavin synthesis even though gro;vth was not inhibited. Riboflavin 
synthesis can be stimulated by several compounds that presumably are not 
direct precursors of riboflavin. Glycine, tyrosine, hypoxanthine and 
Tween 80 are reported to stimulate flavin synthesis (4%), but flavin 
synthesis ceases when there is a nitrogen deficiency (97)» Uracil was 
shown to strongly inhibit riboflavin production in E, ashbyii, (60), but in 
5, cerevi-siae (30) uracil was shown to stimulate riboflavin synthesis. 
There is some confusion as to when flavins are synthesized. In E» ooti-
(125) and C» gwiZlieTmond'l'i (95) riboflavin is synthesized at a constant 
rate during exponential growth end ceases in the stationary phase of growth. 
But, it was shoTO that A, gossypH (k%) initiates riboflavin synthesis in 
the decelerated phase of growth and continues to synthesize riboflavin 
through the stationary phase of growth. 
Dynamic control 
Bacteria are thou^t to respond to environmental stresses by altering 
their metabolic patterns in order to grow as rapidly as possible in their 
environment (8I), IDynamic control, induction-repression (21, 4$) and 
negative feedback inhibition (53, 113, 131) maintain the balance of 
intermediary metabolism within the organism. Mcllwain (63) revaluated 
published data on vitamin synthesis and showed that the vitamins were 
synthesized at a rate about 1000 times less than the rate at which amino 
acids were synthesized. His report also showed that the vitamins were 
overproduced in all the bacterial systems that he evaluated. 
Il* 
Repression of the minor pathways 
Mcllwain (65, 67) reported that pantothenate was synthesized at a rate 
from 0.7 to 1.6 nmoles per mg dry weight of organisms per hour depending 
upon the culture medium. He reported that pantothenate "biosynthesis starts 
at once without lag with a higher rate of synthesis during the production 
of the first few nmoles of pantothenate hy the youngest cells. The rate of 
synthesis changes during different phases of growth as well as during growth 
in different culture media, Lacelles and Woods (5^) reported that when 
Baotevium aot-i and Staphylococcus aureus were grown in the presence of 
sulfonamides and when p-aminobenzoateless mutants were grown on limiting 
amounts of pABA, the organisms became deficient in folic acid. But, the 
resting cell suspensions had an increased ability to synthesize folic acid­
like compounds from pABA. Wilson and Pardee (125) reported that resting 
cell suspensions of E, coZi, synthesized flavins at a slower rate if the 
organism had been previously grown in a minimal medium instead of a rich 
medium. Collectively, this has been taken as indirect evidence for an 
induction-repression mechanism for the regulation of the enzymes in the 
minor pathways. 
Pai and Lichstein (78) examined the effect of exogenous biotin upon 
biotin synthesis in cultures of E, coZ-i when enzyme synthesis was inhibited 
by chloramphenicol or ultraviolet irradiation. They found that when cells 
were grown in the presence of biotin and transferred to a medium with 
chloramphenicol and lacking biotin, then the organism couldn't synthesize 
biotin. However, when cells were grown in the absence of biotin and trans­
ferred into a medium with chloramphenicol, then the cells synthesized biotin 
in the presence or absence of biotin. They concluded that this evidence 
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suggested an induction-repression nechanism and ruled out negative feedback 
inhibition. By examining the enzyme system which catalyzed the conversion 
of (±)-desthiobiotin to (+)-biotin in resting cell suspensions of E. coti. 
and a biotinless mutant of E. aol-it it was shown that the enzyme activity 
vas absent in cells grown in the presence of (+)-biotin (79). The enzyme 
system was shown to be rapidly formed in a basal medium during early 
exponential phase of growth and repressed during the later phases of growth 
(80). Complete repression occurred only when the biotin content of the 
medium was raised above the intracellular concentration that was found in 
cultures upon the cessation of growth (80), 
MacCormick et aZ, (59) showed that the level of pyridoxal phospho-
kinase in a thiamineless mutant varied with the concentration of thiamine 
in the growth medium, Imsande and Pardee (38) showed that the specific 
activity of the first enzyme of the pathway from nicotinic acid to 
nicotinamide adenine dinucleotids varied at least 200-fold depending upon 
the growth conditions. The enzyme was not subject to feedback inhibition. 
Feedback inhibition of the minor pathways 
Negative feedback inhibition was indirectly demonstrated by the use of 
whole cells and medium supplemented with large quantities of the vitamin 
(78, 125). Biotin biosynthesis in E» coti. was not subject to feedback 
inhibition. E, coZi (125) and A. gossyp-i-i (61) were reported to be imperme­
able to added flavins; therefore, it was impossible to determine the effects 
of flavins upon the enzyme activity in whole cells. 
Mathis and Brown (62) presented evidence that dihydroneopterin 
aldolase, an enzyme of the folate pathway, is subject to competitive 
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inhibition by hydroxymethyldihydropteridine, one product of the enzymatic 
reaction. The other product, glycolaldehyde, had no effect upon the enzyme, 
6-Formyldihydropteridine vas also shown to be a potent inhibitor of the 
reaction. At very high concentrations, dihydropteroate and dihydrofolate 
also caused about a 30% inhibition of the enzyme. 
Constitutivity of the minor pathways 
Flavins were reported to be synthesized at a constant rate in excess 
of that required for growth in E, coti (125), A, gossypii (Uit) and C. 
gui-tti-ermodi-i- (95» 96, 97). The folic acid-like compounds were also shown 
to be synthesized in excess and apparently at a constant rate (5U, 75). 
It vas suggested that excretion of an end product of a biosynthetic path-
vay indicates a control mechanism too weak to prevent oversynthesis (27, 
7^, 125). Wilson and Pardee (125) reported that the ratio of excreted 
flavins to intracellular flavins was between 0.8 and 8 during exponential 
growth under different growth conditions compared to about 0.01 for many 
amino acids. In addition, it was shown that vitamin biosynthesis continues 
in the absence of growth (5^, 65, 75, 125). Since vitamin biosynthesis is 
not precisely adjusted to physiological needs, Pardee and Beckwith (82) 
suggested that a steady production of vitamin enzymes at a rate sli^tly 
greater than is essential for grovrth (constitutivity) is more economical 
than an elaborate control mechanism and regulated amounts of an enzyme. 
IT 
EXPERIMENTAL PROCEDURE 
Staphylococcus epidermidis ^ herein designated as strain W, vas 
isolated and characterized "by Koft and co-workers (10, Tl, 123, 12lt). The 
organism was selected for its ability to excrete copious quantities of 
folic acid-like compounds (see Appendix Table 1 for the morphological and 
biochemical characteristics). Stock cultures of the organism were 
maintained on Trypticase Soy Agar (ISA) slants at U C and were transferred 
at 3-month intervals. 
Synthetic medium 
The synthetic medium was derived from the formula for Difco Folic Acid 
Assay Medium (FAAM) (26) by omitting sodium citrate, adenine, guanine, 
uracil and all vitamins except niacin. The final composition of the syn­
thetic medium was: glucose, 10 g; vitamin free cas amino acids, 6 g; 
Z-cystine, 0.1 g; Z-tryptophan, 0.1 g; nicotinic acid, 0.001 g; MgSOj^-THgO, 
0.2 g; I-hSOj^, 0.01 g; FeS0j^*TH2O, 0.01 g; KgHPOj^, 1.2 g; KH^PO^^, 0.8 g; and 
deionized water, 1000 ml. The medium was adjusted to pH 7.4 and then was 
autoclaved for 12 min at 121 C. 
Pyruvate medium 
A stock solution of amino acids was prepared and contained: %-glutamic 
acid, 1000 mg; Z-aspartic acid, 900 mg; Z-proline, 800 mg; Z-tryptophan, 
100 mg; Z-valine, 800 mg; Z-leucine, 900 mg; Z-isoleucine, 300 mg; 
Z-lysine,. 500 mg; Z-threonine, 300 mg; Z-arginine, 500 mg; and deionized 
water, 1000 ml. The stock solution of amino acids was autoclaved for 15 
min at 121 C and stored at h C. The Z-cystine, 200 mg, was dissolved in 
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100 ml of deionized water to vhich 0.83 ml of concentrated HCl had "been 
added, autoclaved and stored at U C. The Z-cystine solution was added 
separately to the final medium. The final medium contained; sodium 
pyruvate, 5 g; amino acid solution, 100 ml; cystine solution, 10 ml; 
nicotinic acid, 0.001 g; thiamine, 0.001 g; MgSOj^.THgO, 0.2 g; î-înSOj^, 0.01 
g; FeSO^'THgO, 0.01 g; KgHPO^^, 7 g; KH^PO^^, 3 g; and deionized water, 890 
ml. ÎBie complete medium was adjusted to pH 7.h and then was autoclaved 
for 12 min at 121 C. 
Growth in defined medium 
To adapt 5. epidevmidis to grow in a defined medium, a heavy inoculum 
from a 2l*-hr TSA slant was added to 100 ml of either the FAAM, the pyruvate 
medium or the synthetic medium in a 250 ml Erlenmeyer flask and incubated 
for 12 hr at 25 C. Then the flask was incubated for an additional l8 hr at 
35 C. There was no agitation of the culture medium during this initial 30-
hr incubation period. A subculture using a 10^ inoculum was made into a 
second flask of the defined medium. The second flask remained stationary 
for 3 hr and then was shaken on a gyrotory shaker (Kew Brunswick Scientific) 
for an additional 12 hr. The second flask was used as an inoculum for the 
growth studies. Both a ten^erature shift and low O2 tension are essential 
in order to get S, epidermidis to grow in serial transfer in any of the 
defined media used. There is very poor growth (about 5 X 10^ bacteria/ml) 
in the initial subculture into a defined medium, but growth is excellent 




5. epi-dex'midis was grown on a gyrotory shaker at 35 C in 1.5 1 of 
jnediiua in a Fembach flask. At intervals during growth a 110 nl sample was 
removed. The optical density vas read directly on a Spectronic 20 colori­
meter (Bausch and Lomb) at 520 nm for the synthetic and pyruvate media and 
at 5^0 nm for the FAAI-I. Then the sample was diluted with sterile growth 
medium until a reading between 0.15 and 0.20 could be obtained. The 
observed reading was multiplied by the dilution factor to give a value 
called the corrected optical density (OD^). The cell arrangement was 
examined under an oil immersion objective on a bright field microscope and 
then the number of organisms were determined with viable plate counts on 
ISA spread plates. Finally, the cells from the remaining 100 ml of culture 
medium were collected on a pre-washed, pre-weighed Millipore filter, 4? mm 
diameter and 0.22 micron pore size (Millipore Filter Corporation). The 
cells were washed with 25 ml of water and dried in a vacuum oven at 65 C 
until they reached a constant wei^t. 
The corrected optical density is proportional to mass (U9). The slope 
is different for each medium since there is a difference in both cell size 
and cell arrangement of S, epidemridis depending upon the growth conditions 
(see Appendix Fig. 1). Dry weight estimates can be made directly from a 
corrected optical density value with the aid of a standard curve of CD 
c 
plotted against mass in a given medium. Thus, OD^ and dry weight will be 
used interchangeably as a measure of growth. 
Viable plate counts of 5. epidevntidis are an inadequate measure of 
growth because the cell arrangement varies from predominately single 
organisms to pairs, tetrads, and clusters depending upon the phase of 
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growth and the growth medium. 
Extraction of intracellular folate and riboflavin 
Cells from 100 ml of culture medium were centrifuged at 29,000 X G for 
5 nin and washed once with 10 ml of deionized water. The cell pellet was 
resuspended in 5 ml of a 0.01% solution of Tween 80 and put into a screw 
cap tube. Toluene was added (1:10, v/v) to the cell suspension and tube 
was sealed and wrapped with aluminum foil to keep out light. The cell 
suspension was shaken on a Burrell wrist action shaker for 15 min at room 
teniperature, then placed into a boiling salt brine (105 C) for 15 min, 
removed and shaken for an additional 10 min. The cap was removed, the 
toluene was driven off by boiling and the cell debris was removed by 
centrifugation at 29,000 X G for 20 min. The supernatant was collected, 
the volume was adjusted to 5.0 ml with deionized water and then the 
supernatant was examined for the quantity of folate and riboflavin 
extracted from the cells. 
Paper chromatography 
Samples (0.001, 0.01, and 0.1 ml) were spotted onto Whatman No. 3M 
paper and were developed to a height of 25 to 30 cm by ascending chroma­
tography in Solvent A (O.l M potassium phosphate buffer, pH T.O), Solvent 
B (the organic phase of n-butanol;glacial acetic acid;water, h:l:5) or 
Solvent C (n-propanol:l^ NHj^OH, 2:1) (see Appendix Table 2 for values of 
standard pteridine, folate and riboflavin compounds). 
The chromatograms were examined under ultraviolet light (25^ nm) to 
detect absorbance or fluorescence. The folic acid-like confounds and the 
riboflavin derivatives were qualitatively detected by the technique of 
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ti©autography (see Bioautography). 
To detect radioactive compounds separated "by paper chromatography, the 
developed and dried chromatogram was marked into 1-cm increments from the 
origin to the solvent front and in 3-cm widths (25). The 1 X 3 cm strips 
were removed and inserted into individual counting vials filled with 10 ml 
of scintillation cocktail (see Detection of radioactivity). The counting 
efficiency was determined "by the channel ratio method and ranged from 
89^ to 9h%. 
Biological assay organisms 
Streptococcus faecium (ATCC #80^3, Streptococcus faecaZis R) was used 
for the biological assay of pteroic acid-like and folic acid-like compounds 
in Folic Acid Assay Medium (Difco). Lactobacillus casei (ATCC #7^69) was 
used for the biological assay for either pteroyl-y-polyglutamate in Folic 
Acid Assay PGA Broth (BBL) or riboflavin compounds in Riboflavin Assay 
Medium (Difco) (see Appendix Table 2 for the type of compounds to which 
each organism will respond). Both organisms were maintained in stab 
cultures of Micro Inoculum agar and subcultured into 5 ml of Micro Inoculum 
Broth (MIB), The cells were washed three times in sterile assay medium 
prior to use as an inoculum for the biological assays. For use in the 
tube assays, 5. faecali-s was diluted 1:100 in sterile FAAI'I and L, casei. 
vas diluted 1:50 in the appropriate sterile assay medium for the determina­
tion of either p te royl-y-poly glutamate or flavins. For bi oautography, the 




The quantities of flavins and folic acid-like compounds were determined 
•fay a modification of the tube assay procedures as described in the Difco 
manual (26). To determine the quantity of pteroate and folate compounds, 
the material to be examined was diluted, then known volumes of the diluted 
material were added to tubes containing 2,5 ml of double strength FAAM and 
the final volume was brou^t to 5 ml with water. The tubes were stoppered, 
autoclaved 12 min at 121 C, cooled, inoculated with 0.1 ml of washed and 
diluted (1:100) cells of S. faecatis and incubated at 35 C for l8 hr. The 
growth response was determined turibidimetrice0.1y with a Spectronic 20 
colorimeter at 5^0 nm. 
To determine the quantity of folic acid and pteroyl-Y-polyglutamate, 
the procedure was the same as for the pteroate and folate compounds except 
that Folic Acid Assay PGA Broth (BBL) was used with diluted (1:50) L, aasei-
as the assay organism. 
To determine the quantity of flavins, the tubes were prepared as for 
pteroates and folates except Riboflavin Assay Medium was used with L, casei 
as the assay organism. The incubation time was extended to 36 hr before 
the growth response was determined. 
For each assay, a standard curve of growth response plotted against 
the concentration of either folic acid (0.05 to 0.5 ng/ml) or riboflavin 
(0.5 to 25 ng/ml) was determined. The quantities of biologically active 
compounds are referred to as 'folate equivalents' or 'riboflavin equiva­
lents' depending upon the specific assay organism and assay medium. 
Bioauto graphy 
The method of tetrazolium bioautography as reported by Usdin, et ai» 
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(ilk) was modified to detect either folic acid-like compounds or flavins 
vhich have been separated hy paper chromatography. To detect folic acid­
like compounds, a base layer of 300 ml of FAAM with 2% agar was inoculated 
with washed cells of faecalis from a 5 ml MIB subculture and poured into 
a baking dish (22 X 3^ cm). After the base layer solidified, a developed, 
dried chromatogram was placed onto the base layer. Then a 250 ml overlay 
of 2% agar containing triphenyl tetrazolium chloride (l mg/ml) was added. 
The baking dish was covered with aluminum foil and was incubated at 35 C 
for 12 hr. 
The procedure to detect flavin compounds is similar to that used for 
folates except that L, casei. was used for the assay organism and Riboflavin 
Assay I'fedium was used for the base layer. 
Compounds which satisfy the folate requirement of 5. faecatis or the 
riboflavin requirement of L» casei- will support the growth of the appropri­
ate assay organism in the base layer. VJhen the organism grows, the 
triphenyl tetrazolium chloride is reduced and results in a red zone on the 
chromâtogram from which the value can be determined. 
Detection of low-folate mutants 
5. evidermldis vas grown in FAAM, diluted and spread over the surface 
of pour plates containing FAAM with 2.% agar which had been previously 
inoculated with washed S. faecdVis (10^ organisms/ml). Colonies of 5. 
epiâevmidis which excrete folic acid-like compounds will grow and the 
excreted folates will difuse into the agar. The excreted folic acid-like 
coETOOunds satisfy the folate requirement of S, faecalis and the assay 
organism grows in the agar. Thus, the colonies of 5. epidermidis which 
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excrete folates will have a halo of growth (about 4 mm in diameter) of S, 
fazcdlis "below it in the agar layer. Mutants of 5. eyidermidis which 
excrete little or no folic acid-like compounds will have no visible halo 
of growth in the agar below the colony. Such mutants were picked, streaked 
onto FAAM, examined microscopically and then examined for the presence of 
catalase to differentiate "between a mutant of 5. epi-dermidis and any 5. 
faecali-s which may have been picked. 
Preparation of cell—free extracts 
Ballantini beads (75 to 105 microns) were added to a washed cell pellet 
of Sm epidarmidis until a thick, sticky paste was formed. The paste was 
sonicated (Raytheon, Model 101) for 2 min; the supernatant was poured off 
and placed in an ice bath; the paste was resuspended in 2 ml of 0.1 M tris-
(hydroxynethyl)aminomethane buffer (Tris), pH 8.0; the cell suspension was 
sonicated for an additional 2 min after which the supernatant was removed 
and placed in an ice bath. This process was repeated until the supernatant 
lost the characteristic opalescence. The cell-free extracts were pooled 
and then the cell debris was removed by centrifugation at 29,000 X G for 
30 min. 
Protein was determined either by the colorimetric method using Biuret 
Reagent (22) or the ratio of ultraviolet absorption at 280 nm and 260 nm 
(119). 
Assay for riboflavin synthetase 
The activity of riboflavin synthetase in crude cell-free extracts was 
determined by the procedure reported by Plaut (88). The cell-free extracts 
were incubated with 6,7-dimethyl-8-(l'-D-ribityl)lumazine, 0.25 nilî; NaHSO^, 
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0.3 JnM; potassium phosphate at pH 6.9» 16,7 mM; in a final volume of 1 ml 
for 60 win at 37 C. At the end of the incubation period, the quantity of 
riboflavin synthesized from 6,7-dimethyl-8-( 1 *D-ribityl)lumazine vas 
determined by biotube assays. The following controls were used for each 
assay for riboflavin synthetase: to determine the amount of non enzymatic 
synthesis of riboflavin from the substrate, the enzyme was omitted from the 
reaction mixture; to determine the amount of endogenous riboflavin in the 
cell-free extracts, the enzyme was denatured by boiling before adding it to 
the reaction mixture; and to determine the quantity of endogenous precursors, 
the substrate was omitted from the reaction mixture. All data have been 
corrected for the endogenous riboflavin activity. 
Assay for pteroate synthetase 
The activity of pteroate synthetase in crude cell-free extracts was 
determined by the procedure reported by Jones and Williams (Uo). The cell-
free extracts were incubated with 2-amino-4-hydro%y-6-hydroxymethyldihydro-
pteridine, 0.05 mM; p-aminobenzoic acid, 1.5 mI4; adenosine-5'-triphosphate, 
O.U mM; MgClg* 1 mM; ascorbic acid, 5 mM; potassium phosphate at pH 7.8, 
0.1 M; in a final volume of 1 ml for 60 min at 37 C under a layer of 
mineral oil. At the end of the incubation period, the total quantity of 
pteroate confounds synthesized from the substrate was determined by biotube 
assays, Ccxitrols were similar to those used for the riboflavin synthetase 
assay to determine both nonenzymatic and endogenous folate activity. All 
data have been corrected for the endogenous folate activity. 
Assay for CTP-cycldhydrolase 
Cell-free extracts were incubated with GTP-8-^^C (0.3 mM, 1,5 X 10^ 
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DPM) and 0,1 M potassium phosphate at pH 8,0 in a final volume of 0.5 ml 
for 30 min at 39 C under an atmosphere of argon. The reaction was stopped 
with 0,1 ml of 89îa formic acid and the enzyme activity was measured by the 
quantity of radioactive formic acid released from GTP. 
Celite chromatography 
Formic acid was separated from the substrate by column chromatography 
on Celite 535 (Johns-Manville) (102, 107). The Celite was prepared using 
a modification (127) of the procedure reported by Swim and Utter (ill). 
Then the Celite (0.7 g) was acidified with 0.35 nil of 0.2 N HgSO)^ and 
packed into a column (1.2 X 5»0 cm) with a glass rod. A 0.2-ml sample from 
the GTP-cyclohydrolase assay mixture was placed onto the column. The column 
was washed with 8 ml of chloroform saturated with 0.2 N HgSO^ and the 
chloroform fraction was discarded. Then the column was eluted with 1 -ml 
fractions of 1-butanol in chloroform saturated with 0.2 K HgSOj^ (1:^, v/v). 
The eluent was collected in l-ml fractions and examined for radioactivity 
(see Detection of radioactivity). 
Purification of GTP-eyelohydrolase 
The crude cell-free extracts were incubated with ribonuclease (50 yg/ml) 
and deoxyribonuclease (10 yg/ml) for 20 min at 37 C. Then the extracts 
were heated at 60 C for an additional 20 min and centrifuged at 29,000 X G 
for 20 min. The supernatant was treated with 1% streptomycin sulfate (w/v) 
for 30 min at 4 C to precipitate the remaining nucleic acids. This mixture 
was centrifuged at 29,000 X G for 20 min and the precipitate was discarded. 
The supernatant was desalted on a column (2.5 X 90 cm) of Sephadex G-25 
which had been previously equilibrated with 0.1 M Tris buffer at pH 8.0. 
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The initial protein peak, approximately the first 60 ml after the void 
volume, contained all the GTP-cyclohydrolase activity» Solid ammonium 
sulfate was added to the eluent to give a 60^ saturated solution. The 
precipitate was resuspended in 15 ml of 0.1 M Tris buffer, pH 8.0, and 
added to a column (2.5 X U5 cm) of Sephadex G-75 and developed with 0.1 M 
Tris "buffer, pH 8.0. 
Three peaks of enzymatic activity were eluted from the Sephadex G-75 
column with Tris buffer. On the basis of retention volume and added 
ribonuclease as a marker protein, the molecular weight of the protein in 
each peak was estimated to be: Peak I, greater than 75,000; Peak II, 
between 20,000 and 50,000; and Peak III, between 10,500 and 20,000. There 
was about a 200-fold purification of the GTP-cyclohydrolase enzyme in Peak 
I over the crude extract. Since the enzyme found in Peak I released about 
5 times more free formic acid per unit weight of protein than the enzymes 
in either Peak II or Peak III, the partially purified enzyme from Peak I 
only was used for further studies. Although only a small quantity of free 
formic acid was released from GTP by the enzyme in either Peak II or Peak 
III, a second peak of radioactive formic acid was eluted from the Celite 
column (see Appendix Fig, 2), The second peak of radioactive formate is 
believed to come from, a bound formyl group and is slowly cleaved and 
released as formate by the acid environment of the Celite column. 
Heat activation of GTP-cyclohydrolase 
Prior to use, 1 ml of crude cell-free extract was heated in a boiling 
water bath for 5 min. The denatured protein was removed by centrifugation 
and the protein concentration of the supernatant was determined. The 
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supernatant vas incubated with GTP-8-^^C to determine the specific activity 
of the he at-s table GTP-cycl ©hydrolase. The heat treatment increased the 
specific activity about 10 fold, but the elutioa pattern of formate from 
Ce lite indicated that there was a large quantity of bound fornyl as well 
es free formate (see Appendix Fig. 2). 
Detection of radioactivity 
Radioactivity, measured as disintegrations per minute (DPI-l), was 
determined by the channel ratio method in a Beckman scintillation spectro­
photometer (Model DPM 100). The scintillation fluid was composed of 0,5% 
2,5-diphenloxazole and 10^ napthalene in 1,4-dioxane. 
Materials 
Micro Inoculum Broth, Folic Acid Assay Medium and Riboflavin Assay • 
Ifedium were purchased from Difco Laboratories. 
Folic Acid Assay PGA Broth and Tiypticase Soy Broth were purchased 
from Baltimore Biological Laboratories, 
Napthalene and 1,4-dioxane were purchased from J. A. Baker Chemical 
Company» 
The 2,5-diphenyloxazole was purchased from Beckman Instrument Company. 
Sephadex G-25, Sephadex G-50, Sephadex G-T5, Sephadex G-IOQ, Sephadex 
G-200 and Blue Dextrin 2000 were purchased from Pharmacia Fine Chemicals, 
Inc. 
Adenosine-5'-triphosphate, guanosine-5'-triphosphate, guanosine-5'-
triphosphate-8-l^C, guanosine-5*-triphosphate-U-^^C, folic acid, strepto-
nycin sulfate, tris (hydroxymethyl)aminomethane and sodium borohydride were 
purchased from Schwarz Bi©chemicals, Inc. 
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Ribonuclease B and deoxyribonuclease II were purchased .from 
Worthington Biochemical Coip, 
Folic acid-2-^^C was purchased from Amersham/Searle. 
The 2-amino-l(-hydroxy-6-hydroxymethyl pteridine was synthesized "by 
L. P. Jones by the method described by Baugh and Shaw (8). Sodium boro-
hydride was used to reduce 2-amino-ij-hydroxy-6-hydroxymethylpteridine to 
2-amino-I|-hydroxy-6-hydroxyinethyldihydropteridine (104 ). The N^^-formyl-
pteroic acid was synthesized by L.~P. Jones using the method of Wolf, et 
al. (128). 
The 2-amino-I<-hydroxy-6-formylpteridine and the 2-amino-i|-hydroxy-6-
carboxypteridine were synthesized by F. D. Williams using the method of 
Waller, et at, (ll8). 
The 2-amino-4-hydroxy-6-(D-srz/tTzro-l' ,2' ,3*-trihydroxypropyl)pteridine 
(D-neopterin) was synthesized by M. LeVaie using the method of Rembold and 
Metzger (91) and purified by the chromatographic method of Rembold and 
Bushmann (90). The 2-ainino-4-hydroxy-6-(L-6r^t%ro-l' ,2' ,3'-trihydroxypropyl) 
pteridine (L-neopterin) was a gift from G. W. Kidder. 
Leucopterin, xanthopterin, isoxanthopterin and 6,7-dimethy1-8-(1'-D-
ribityl)lumazine were purchased from Fltika Chemische Fabrik, 
Eie 2-ajaino-lt-hydroxypteridine and 2-amino-!t-hydroxy-6,7-dimethyl-
pteridine were purchased from Regis Chemical Company. 
The lumazine was purchased from Aldrich Chemical Con^iany, Inc. 
The biotin was purchased from Nutritional Biochemical Company. 
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RESULTS 
Preliminaiy studies showed that 5. ep-idevmidis excretes into the 
culture mediuiE large quantities of "both folic acid-like compounds, which 
will support the growth of S» faeoali-s  ^ and riboflavin-like compounds, 
which will support the growth of L. oase-i. The morphological and biochemi­
cal characteristics of S, epidermidis have remained essentially unchanged 
during this investigation with the exception of a change in two types of 
folic acid-like compounds that are excreted (see next paragraph). 
Folate and riboflavin excretion by 5, epidermidi-s 
S, epidermidis was grown in 1.5 1 of Brain Heart Infusion broth (BHI), 
FAA.M and synthetic medium in 2.8 1 Fembach flasks with agitation on a 
gyrotory shaker. At itervals, a 100-ml sample was removed and centrifuged. 
The supernatant was examined for excreted folic acid-like compounds and 
excreted flavins. The cell pellet was washed and the intracellular folates 
and flavins were extracted. The quantity of intracellular and extracellular 
folates and flavins was determined by tube bioassay. The types of 
compounds excreted into the growth medium were separated by ascending paper 
chromatography in Solvent A (see Appendix Table 2 for values of standard 
confounds) and located by bioautography. Table 1 shows the R^ values of 
the excreted folic acid-like compounds which are biologically active for 
S, faecaZ-is and the excreted flavin derivatives which are biologically 
active for L, casei. Riboflavin (R^ 0,36) and traces of flavin mono­
nucleotide (FÎ#) are the only flavin derivatives excreted; whereas pteroic 
acid (R^ 0,01), a compound thought to be pteroate pyrophosphate (R^ 0,79) 
and rhizopterin derivatives (R^. 0.4? and 0.6l) are the typical folic acid-
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Table 1. The values in Solvent A for the biologically active folate 
and flavin derivatives excreted into the culture medium by 5, 
e'g-idevmidi-s in the stationary phase of growth. 
Growth Medium Folic Acid-like Flavin 
Derivatives Derivatives 
BHI 0.60 0.36 
0,01 








like compounds excreted. But, when S. epidermidis is continuously sub-
cultured in the synthetic medium, the 0.79 compound is lost with the 
concomitant appearance of a compound with an R~ 0.11 (believed to be a 
rhizopterin derivative). In the synthetic medium, the concentration of 
each pteroate derivative changes during growth. In the accelerated phase 
and early exponential phase of growth only pteroic acid is found. During 
exponential growth, the pteroate concentration decreases and compounds with 
an of 0,38 and O.U7 appear in relatively high concentration. Then 
during the decelerated exponential phase and stationary phase of growth, 
the 0.38 compound disappeares completely with increasing concentrations 
of pteroic acid and compounds with an R of O.56 and 0,79. Since the 
X 
biotube assay does not distinguish between these various derivatives and 
the standard curve is prepared with authentic folic acid, the quantity of 
folic acid-like compounds will be expressed as 'folate equivalents* and the 
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conçoiinds will "be referred to as folates. But, it should he understood 
that folic acid per se (R^ 0.35) is not found in the culture supernatant. 
Fig, 1 and 2 show the intracellular and extracellular quantities of 
both folate and riboflavin during the growth of S, epidermidis in BHI and 
FAAI'Î. Biotube assays were used to determine the quantity of endogenous 
folate and riboflavin in the BHI medium and the quantity of riboflavin in 
the FAAM. The extracellular values for folate and riboflavin shown in 
Fig. 1 and the extracellular values for riboflavin shown in Fig, 2 have 
been corrected for the amounts of vitamins initially present in the media. 
Fig. 3 shows only the folate levels observed during growth of S. epidermidis 
in the synthetic medium. The graphic presentation of the riboflavin levels 
was omitted because there were no seaiples examined for riboflavin during 
the mid-exponential phase of growth. The shape of the riboflavin curves 
are similar to the shape of the curves for cells grown in FAAÎ-1. However, 
in the stationary phase of growth, the intracellular concentration of 
flavins is 5.2 times greater than the extracellular concentration and the 
total flavins excreted into the synthetic medium is about one-fifth as much 
as the total flavins excreted into the FAAI-I. 
The quantity of excreted folates always exceeds the intracellular 
quantity of folates (Fig. 1, Fig. 2, Fig. 3). In addition, the amount of 
excreted folates is a close approximation of the total quantity of folates 
synthesized, especially for cultures in the stationary phase of growth. 
However, the quantity of intracellular riboflavin from cultures in the 
stationary phase of growth approaches or exceeds the quantity excreted into 
the culture medium. During growth, the intracellular concentration of 
riboflavin remains constant, but the folate concentration does not remain 
Fig. 1. The quantities of intracellular folates (Q), excreted folates 
(©), intracellular riboflavin (•) and excreted riboflavin ( Q) 
synthesized by S, ep-CderntCdis during growth in BHI. A typical 
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Fig. 2, The quantities of intracellular folates (O), excreted folates 
(O), intracellular riboflavin (•) and excreted riboflavin ( O) 
synthesized by S, epzdermiàis during growth in FAAI^, A typical 
growth curve for S, ep'idevmidi.s in FAM-l is shown by the solid 
line. 
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Fig. 3. The quantities of intracellular folates (B) and excreted 
folates (©) synthesized "by S, epidermidi-s during growth in the 
synthetic medium, A typical growth curve for S, epidermidis in 
the synthetic medium is shown by the solid line. 
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constant. Also, there is an apparent loss of folate activity from the 
culture supernatant during exponential growth which can not be explained 
ty just uptake of folates into the cell. Either the folate compounds are 
taken up and are hound or they are altered to compounds such as unconjugat­
ed pteridines or pteroyl-y-polyglutamates which are not biologically active 
for 5, faecatis. Since L, aasei will respond to the pteroyl-y-polyglutamates 
as well as to folic acid and fornylated folate but not to the pteroate 
derivatives, the spent culture medium was examined for biological activity 
with both L, casei. and S. faeoat-is. Table 2 shows the absence of either 
pteroyl-y-polyglutamates or folic acid in the culture medium during expo­
nential growth and early stationary phase of growth. But, in late station­
ary and early death phase, compounds other than folic acid that are active 
for Lt casei but not S. faecatis are excreted in increasing quantities 
apparently at the expense of the pteroate compounds. 
To determine whether folic acid could enter the cell and be either 
bound or altered, S, epidermidis was grown to stationary phase in 100 ml 
Table 2. The absence of extracellulair folic acid and pteroyl-y-poly­
glutamates in the culture medium of young cultures of 5. 
epi-derntidis grown in FAAî«I. 
Age of Culture Folate Equivalents in ng/ml 
in hours S, faeoaZi-s L, casei. 
4 85 0 
6 15 0 
8 3 0 
18 SU 0 
30 191 
96 331 101 
120 • l81i 235 
of synthetic medium supplemented with folic acid-2-^^C (10 yCi; 0.8 yg/ml). 
The culture supernatant was removed by centrifugation and exatair,ed for 
radioactive compounds. The cells were washed, re suspended in 2,5 ml of 
vater and the intracellular folates were extracted. The extracted cells 
vere washed, resuspended in 2.0 ml of water and examined for bound folates. 
Based upon the quantity of radioactivity recovered in each fraction, it was 
calculated that 77«3 Wg of the originally supplemented folate remained in 
the culture medium while 0.1iU8 yg could be extracted and 1.3^ yg was 
"bound. The bound radioactivity could be released with acid hydrolysis in 
6.1 N HCl at 121 C for 1 hr. To determine whether the folic acid was 
changed, a 0.1 ml aliquot from each fraction was spotted onto Whatman No, 
SMT'I paper and developed by ascending chromatography in Solvent A and 
Solvent B. The chromatograms were examined for fluorescence under UV light 
(251* nm), radioactivity and biological activity for S, faecalis. Table 3 
shows the distribution of radioactivity between and within each fraction as 
we]J. as the values in Solvent A for the biologically active conroounds 
for S, faeaaZi-s. It is clear that folic acid can enter the cell; it can be 
altered to pteroate derivatives ; and it can be bound. No unconjugated 
pteridines were detected on the basis of fluorscence under UV light or on 
the basis of the values of the radioactive compounds, 
Œ5ie levels of excreted folates are 20 to 100 times higher than intra­
cellular folate levels in stationary phase cultures of S. epidermidis. 
Assuming that a large extracellular to intracellular ratio (E/l) indicates 
that a biochemical pathway is not subject to exact regulation, then the 
folate pathway in S. epidermidi-s strain W is not subject to exact regula­
tion, If this assumption is correct, then it would follow that an organism 
4l 
Table 3. The distribution of bound, intracellular and extracellular 
radioactive compounds derived from folic acid when 5. epidar-
is grown in synthetic medium supplemented with folate-2-^^C. 
Fraction Distribution of values of Distribution of 
Radioactivity Biological Activity Radioactivity 
Between Fractions Within Fractions 
in % Solvent A in % 
Uninoculated 100 0.00 0,1 
Ifedium 0.35 97,7 
Spent Culture 97.3 0.00 4.1 
jjsdium 0.1*3 69,1* 
0,61 16,2 
0.78 6.5 
Extractable 0,56 0.00 18,9 
Folates 0.36 39,8 
0,60 20,1 
0,79 11.9 
Bound Folates 1.67 
Released by 0,00 7.1 
acid hydrolysis 0,1*9-0,65 88,3 
which excretes little or no folate would be subject to a more exact regu­
lation, Based upon these assumptions, I looked for either a strain or a 
mutant of 5. epidemnidis which would excrete little or no folic acid-like 
conroounds. Eight strains of S, epidermidis were obtained from R. W. Brown, 
the National Animal Disease Laboratories (NADL), Ames, Iowa, The growth 
characteristics, the types of folic acid-like compounds excreted and the 
quantity of folates excreted from the NADL strains were compared to 5. 
epidemridis strain W and two mutants derived from strain W (mutant ÏÏFA and 
mutant NFB). All the strains of 5, epidermidi-s that were examined and that 
will grow in the synthetic medium excrete an excess of the same types of 
h2 
folic acid-like compounds (See Appendix Fig. 3, Appendix Table 3, Appendix 
Table k). 
The 29 apparent mutants of strain W are naturally present in the 
culture of S. epidermid-is at a frequency of 1 per 10^ organisms vhen S, 
epidermidis strain W is continously subcultured in FAAM. The original 
isolates excreted less than 0.75 ng/ml of folates into the growth medium. 
The mutants designated KFA and NFS are characteristic of the whole group 
of matants isolated. All 29 isolates revert to the wild type excretion 
pattern when grown in synthetic medium, 
A comparison of the relative quantities of folate and riboflavin 
excreted by the mutant NFA and the wild type grown in FAAM (Table k) and in 
synthetic medium (Table 5) suggest that the folate and riboflavin pathways 
are inversely related and are adaptive. First, there is an inverse 
relationship between the quantity of folate and riboflavin excreted, 
relatively low folate-relatively high riboflavin, relatively high folate-
relatively low riboflavin. Second, more riboflavin is excreted under 
conditions of low ©2 and high CO2 tension, whereas, folate excretion is 
increased by an increased O2 tension. And finally, there is a response to 
one or more nutritional components in FAAI<I which reduces the folate syn­
thesis and stimulates the riboflavin excretion. Since the mutants could 
not be distinguished from the wild type organism when grown in synthetic 
medium, they were not considered to be under strict regulation as origi­
nally presumed. Rather, I believe they are extreme examples of the adapta­
tion of the folate pathway in response to some nutritional component. 
Therefore, information about the types of nutritional compounds which 
cause changes in folate and riboflavin synthesis and the extent of the 
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Table h, The quantity of folate and riboflavin excreted by 5. epi-dernridis 
strain W and mutant ïïFA when grown in stationary and shake 
flasks of FAA1-Î, 




















2 , k  0.4 1850 
3.6 292.1 1175 
Table 5. The quantity of folate and riboflavin excreted by S. epidermid-is 
strain W and mutant NFA when grown in stationary and shake 
flasks of synthetic medium. 
























changes seemed to be required to define the extent of adaptation of these 
biosynthetic pathways. 
Evidence for adaptive folate and flavin pathways 
To determine which nutritional components of FAAM will stimulate the 
riboflavin excretion and reduce the folate excretion, the citrate, vitamins 
and purine-pyrimidine components of FAAM were euided to the synthetic medium 
so the final concentration of each would be the same as in FAAM: sodium 
citrate, 10 mg/ml; thiamine hydrochloride, 1 yg/ml; pyridoxine hydrochloride. 
kk 
2 yg/ml; riboflavin, 1 pg/ml; p-amindbenzoic acid, 0.1 yg/ml; biotin, 
O.OOOU yg/ml; calcixm pantothenate, 0.2 yg/ml; adenine sulfate, 10 yg/ml; 
guanine hydrochloride, 10 yg/ml; and uracil, 10 yg/ml, 5. epidermi-dis was 
grown in shake flasks to the stationary phase of growth in synthetic medium 
supplemented individually or in combination with either sodium citrate, a 
vitamin mixture or a purine-pyrimidine mixture. Then the culture medium 
was examined for the quantity of excreted folates and riboflavin (Table 6). 
Since the final population of S, epidermidis in each growth medium differs, 
the quantities of excreted folates and riboflavin are corrected for growth. 
Viable plate counts were found to be an inadequate measure of growth since 
Table 6. The effects upon growth and upon the folate and riboflavin 
excretion of S, ep-idermidis when grown to. stationary phase in 
synthetic medium supplemented with the components of FAAî'-I. 








None 2.1;5 345 l4l 83.2 34 
Vitamin Mixture 4.90 113 23 89.2 18 
Citrate 0.17 l4 84 47.5 276 
Purine-pyrimi dine 0.09 25 289 56.2 647 
Vitamin Mixture + 
Citrate 2.72 68 25 225.5 87 
Vitaaân Mixture + 
purine-pyrimi dine 5.4 124 23 460.5 82 
Pur ine-pyrimidine + 
Citrate 0.10 19 195 52.5 526 
Vitamin Mixture + 
Purine-pyrimidine + 
Citrate 3.4 51 15 995.0 293 
Ii5 
S, epidemrid-is can grow predominately either as single organisms, in pairs, 
in tetrads or in clusters depending upon the phase of growth and the growth 
medium. Therefore, growth is measured in terms of corrected optical 
density (OD^) which is proportional to mass (see Appendix Fig. 1). After 
corrections for growth it "becomes evident that when growth is poor, the 
organism excretes a relatively large quantity of folate and riboflavin per 
organism. But, relatively small quantities per organism are excreted under 
conditions which allow for nearly maximal growth. In addition, there is 
something in the purine-pyrimidine mixture which stimulates both folate and 
riboflavin synthesis and something else in the vitamin mixture which 
decreases the synthesis of both. For folate"synthesis, the vitamin effect 
completely negates the stimulatory effect of the purine-pyrimidine mixture. 
But for riboflavin synthesis, the stimulation by the purine-pyrimidine 
mixture overcomes the inhibition caused by the vitamin mixture. 
In an attenrot to find defined media which will allow S, epidermidis to 
synthesize relatively high quantities of both folate and riboflavin, 
relatively low quantities of both folate and riboflavin, relatively low 
folate-high riboflavin and relatively high folate-low riboflavin, each 
vitamin (Table j) and each purine and pyrimidine (Table 8) found in FAAl-i 
vas added separately and as a mixture to the synthetic medium. Xanthine, 
hypoxsnthine, inosine, and 2,U,5-triamino-6-hydroxypyrimidine were also 
individually supplemented into the synthetic medium at a concentration of 
10 yg/ml.(Table 8). The data were corrected for growth and the total 
synthesis is expressed in terms relative to the quantity per corrected 
optical density of the unsupplemented synthetic medium. Again, it is 
evident that when growth is poor, the organism excretes a relatively large 
kS 
Table %. The effects upon growth and upon the folate and riboflavin 
excretion of 5, epideimidi-s vhen grown to stationary phase in 
synthetic medium supplemented with vitamins. 
Additions to the Growth Folate Riboflavin 
Growth î'fediuia OD ng/ml/OD^ Relative ng/ml/OD^ Relative 
Synthesis Synthesis 
None 2.60 149 1.00 37. ,4 1.00 
p-aminobenzoate 0.68 262 1.75 50. 3 1.34 
pyridoxine•HCl 0.73 242 1.62 149. 5 4.00 
Riboflavin 1.82 213 1.43 ,a -
Ca-Pantothenate 2.40 l4i 0.95 39. 3 1.05 
Thiamine•HCl 3.00 115 0.78 35. a 0.96 
Biotin 4.20 3 0.02 3. 7 0.10 
Vitamin Mxture U.Uo 22 0.15 20. 2 0.54 
®Mot determined. 
quantity of folate and riboflavin per organism and a relatively small 
quantity of both when growth is excellent. Oïie additions of p-atninobenzoic 
acid, pyridoxine hydrochloride, uracil and xanthine lowered the initial pH 
of the synthetic medium from pH 7.1* to T«l« I don't believe that pH alone 
vas responsible for the decreased growth since similar results were obtained 
when the pH was adjusted to Of the vitamin compounds tested, biotin 
strongly stimulates growth and drastically reduces both folate and ribo­
flavin synthesis. It is also interesting that pyridoxine hydrochloride 
stimulates the synthesis of both folate and riboflavin. While all of the 
purine and pyrimidine compounds tested inhibited growth to some extent, 
they all stimulated the synthesis of both folate and riboflavin. While 
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Table 8. The effects upon growth and upon the folate and riboflavin 
excretion when S. epidermidis is grown to stationary phase in 
synthetic medium supplemented with purines and pyrimidines. 
Additions to the Growth Folate Riboflavin 
Groirth Medium OD^ ng/ml/OD Relative ng/ml/OD^ Relative 
Synthesis Synthesis 
None 2.1i5 115 1.00 13.5 1.00 
Uracil 0.10 278 2.42 177.0 13.10 
Xanthine 0.19 687 5.97 156.0 11.50 
2,U,$-Triamino-6-
hydroxyoyrimidine 
7.49 SOl^ 0.1i9 319 2.77 101.2 
Inosine 0.31 284 2.47 97.5 7.22 
Guanine*HCl 1.18 22k 1.95 21.2 1.57 
Hypoxanthine 1.72 343 2.98 17.4 1.29 
Adenine'SO^^ 2.10 140 1.22 17.1 1.26 
Purine-pyrimidine 
Mixture 1.82 2.1k 1.86 128.1 9.49 
uracil, xanthine, inosine and 2,lt,5-triamino-6-hydroxypyrimidine have a 
strong stimulatory effect upon the folate and riboflavin excretion, it is 
suprising that guanine has so little effect upon the excretion of either 
vitamin. Table 9 lists the defined growth media and the desired character* 
istics related to folate and riboflavin synthesis which will be used to 
determine the rates of synthesis and specific activities of selected 
enzymes. 
5. epidermidis was grown in 2.8 1 Fernbach flasks containing 1.5 1 of 
synthetic medium, synthetic medium supplemented with k ng/ml of biotin and 
1*8 
Table 9« A summary of the effects of the growth medium upon the relative 
growth and the relative quantity of folates and riboflavin 
synthesized when S. epidermidis is grown to the stationary phase. 
Growth Medium Relative Relative Folate Relative Riboflavin 
Growth Synthesis Synthesis 
Synthetic + 
Xanthine Very Poor High High 
Synthetic Good High Low 
FAAI-I Good Low High 
Synthetic + 
Biotin Excellent Low Low 
FAAM, The synthetic medium supplemented with xanthine was omitted because 
it would not support adequate growth of S, epidermidis for this experiment. 
At intervals during growth, samples were removed, growth was determined by 
corrected optical density, dry weight and viable plate counts. Then the 
culture supernatant was examined for excreted folates and riboflavin and 
the cell pellet was extracted to remove the intracellular folates and 
riboflavin. The total quantity of folate and riboflavin (extracellular 
plus intracellular) is expressed in moles (nmoles/ml) and is divided by the 
mass (mg dry weight/ml) so that the total synthesis is expressed as nmoles/ 
mg dry weight and is plotted against mass doubling (Fig. 4 and Fig. 5). 
Eie generation time of S, epi-dermidi-s is: 28 min in the biotin supplemented 
medium; 37 min in the FAAi4; and 52 min in the synthetic medium. The data 
are distorted if the quantity per cell is plotted against time since the 
organisms grown in the biotin supplemented medium are in the stationary 
phase of growth at the sajce time that the organisms grown in the synthetic 
The total folate synthesis per cell related to growth of S. 
ep-idermidis in the synthetic medium (A), the biotin supplement­
ed medium (O) and the FAAI-Î (•). 
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Esdiun are in the exponential phase of growth. As pointed out previously, 
viable plate counts were an inadequate measure of growth. Therefore, the 
data are plotted as the quantity per mass against the doubling of mass in 
order to approximate a quantity per cell per generation. If the enzymes of 
either the folate biosynthetic pathway or the riboflavin bi©synthetic 
pathway are constitutive and have a constant rate of synthesis per cell, 
then the quantity/mass plotted against mass doubling should be a straight 
line with zero slope. But it is clear from Fig. It and Fig. 5 that the 
rate of synthesis changes for both folate and riboflavin with the possible 
exception of riboflavin synthesis during exponential and stationary phases 
of growth in the biotin supplemented medium. The data indicate that both 
folate and riboflavin are synthesized in excess during the lag phase, then 
synthesis stops or is severly reduced with concomitant dilution of the 
specific vitamins per cell during early exponential phase and finally 
synthesis is again initiated about late exponential phase of growth and 
continues throu^ the early stationary phase. 
To further substantiate the time of vitamin synthesis in relation to 
growth, the specific activity of GTP-cyclohydrolase, the first enzyme 
complex in the folate pteridine biosynthesis, was examined during exponenial 
growth (Fig. 6). At 20 min intervals, starting at early exponential growth, 
samples of S. epidemridis were taken from the synthetic medium and the cells 
were disrupted. The cell-free extracts were heated in a boiling water 
bath to activate GTP-cyclohydrolase (see Appendix Fig. 2). When the spe­
cific activity, expressed in nmoles of formate released from GTP/mg 
protein/ml/hr, of GTP-cyclohydrolase was measured, it was found to decrease 
during early exponential growth followed by an increase during late 
The specific activity of heat treated GTP-cyclohydrolase 
prepared from crude cell-free extracts taken during the 
exponential phase of growth in the synthetic medium. 
SPECIFIC ACTIVITY of heat treated GTP-CYCLOHYDRLASE 





exponential growth. This correlates with the information on the rate of 
total synthesis and reinforces the interpertation that folate synthesis is 
reduced and then later initiated in excess during this period of grmrth. 
Evidence for & branched pteridine pathway 
By taking advantage of the effect of the growth media upon folate and 
riboflavin biosynthesis, the specific activity of enzymes from the pteri­
dine, folate, and riboflavin pathways were examined. The following enzymes 
were selected because there are adequate assay systems for each and because 
each enzyme is known to participate in the synthesis of compounds in the 
pathways in question: GTP-cyclohydrolase, the first enzyme complex in the 
pteridine pathway, cleaves C-8 of GTP and releases it as formate; pteroate 
synthetase, which is two enzymes, adds a pyrophosphate moiety to 2-amino-
I»-hydroxy-6-hydroxymethyldihydropteridine and then adds p-amin©benzoic acid 
to form pteroic pyrophosphate in S. epidermidis i and riboflavin synthetase, 
the terminal enzyme in riboflavin synthesis, makes one molecule of ribo­
flavin from two molecules of 6,7-dimethyl-8-(l'-D-ribityl)lumazine. S, 
epidermidis was grown in synthetic medium, biotin supplemented medium emd 
FAAl-I, Oie cells were collected from the late exponential phase of growth 
and disi*upted. The crude cell-free extracts were used for the assay 
because one of the enzymes, pteroate synthetase, loses its activity if it 
is dialyzed, heated or frozen. Table 10 shows the specific activities for 
the enzymes representative of the pteridine, folate and riboflavin pathways 
and the total quantity of folate and riboflavin synthesized by the organisms 
grown in each medium at the time the samples were taken. There is a good 
correlation between the specific activity of the enzymes and the total 
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Table 10. The specific activity of enzymes representing the pteridine, 
folate and riboflavin pathways in crude cell-free extracts 
prepared from late exponential phase cultures of 5. e'p-idermidis» 
Growth Specific Activity Total Synthesis 
Msdium nmoles/mg protein/ml/hr nmoles/mg dry wt 
GTP-cyclohydrolase Pteroate Riboflavin Folate Riboflavin 
Synthetase Synthetase 
Synthetic 4.100 0.173 0.217 0.92 0.U2 
Synthetic + 
Biotin 0.260 0.006 O.llk 0.03 0.19 
FAAM 0.887 0.007 O.I160 0.06 2.13 
synthesis of the appropriate vitamin compound in a given growth medium. 
The unique feature is that GTP-cyclohydrolase activity remains relatively 
high even when the pteroate synthetase activity is very low (in the biotin 
supplemented medium) and the GTP-cyclohydrolase activity increases dispro­
portionately with a negligible increase in the pteroate synthetase activity 
(in the FAAI>l). This suggests that a product of the GTP-cyclohydrolase 
enzyme maybe required for something other than folate synthesis, possibly 
riboflavin synthesis. The variance of the specific activity of the enzymes 
also suggest that they must be subject to some type of regulation. 
If an organism is supplied with all the products of folate metabolism 
(inosinic acid, thymine, methionine, serine-glycine, etc») then there should 
be little requirement for the biosynthesis of folic acid and the folate 
synthesis should be at a minimum. Conversely, if the organism was grown 
in a medium void of the end products of folate metabolism, then there 
should be a greater demand for folic acid and the folate synthesis should 
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be at a maximum. Thus j it should be possible to shift the folate synthesis 
from near the maximum to the minimum rate of synthesis by the addition of 
one or all the products of folate metabolism. To test this hypothesis, the 
organism was grown in the pyruvate medium (described in EXPERIÎ-ÎSITTAL 
PROCEDURE), When the cultures were in exponential growth, samples were 
removed at 10 min intervals, disrupted and the specific activity of GTP-
cyclohydrolase, pteroate synthetase and riboflavin synthetase were measured. 
After 90 min of growth, the culture was equally divided into two flasks. 
To one of the flasks, some of the end products of folate metabolism 
(thymine, 50 yg/ml; thymidine, 50 yg/ml; serine, 150 yg/ml; glycine, 250 
yg/ml; and methionine, 15 yg/ml) were added. The other flask served as a 
control. For the next 90 min, samples were removed at 10 min intervals and 
the specific activity of the three enzymes were measured. The experimental 
design was based upon the method used by Kovach et al, (51) to demonstrate 
either concomitant or sequential repression of histidine biosynthesis. In 
the control flask without the added inhibitors, it was found that the 
specific activity of all three enzymes rapidly drops, levels off and rapidly 
increases during exponential growth similiar to that already shown for 
GTP-cyclohydrolase (see Fig. 6). The only effect of the added inhibitors 
(Fig, 7 ) was to prevent an increase of the pteroate synthetase activity 
during the late exponential phase of growth and to slightly reduce the rate 
of increase of the GTP-cyclohydrolase activity. The riboflavin synthetase 
activity increased in late exponential phase of growth in the culture with 
the inhibitors at the same rate as the control flask. 
In an attempt to find out if known intermediates of folate or ribo­
flavin synthesis would decrease the specfic activity of GTP-cyclohydrolase, 
Fig. 7. The effect of potential inhibitors (thymine, thymidine, glycine, 
serine and methionine) on the specific activity of GTP-cyclo-
hydrolase (O), pteroate synthetase (A) and riboflavin syn­
thetase (•). The inhibitors were added at time 0, indicated by 
the arrow. The closed symbols represent the specific activity 
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dimethyl-B-ribityll-umazine, 1 yg/ml, and hydroxynethylpteridine, 1 yg/ml, 
vere added to the synthetic medium. The cells vere collected in the late 
exponential phase of growth and disrupted. The crude cell-free extracts 
vere heat treated to activate GTP-cyclohydrolase and then the specific 
activity of the enzyme was determined. In the second part of the exjieri-
ment, the cells from the supplemented medium were washed and inoculated 
into the unsupplemented medium, grown to the late exponential phase and the 
specific activity of GTP-cyclohydrolase was again determined (Table 11). 
Cells grown in the biotin supplemented medium were included as a control. 
The specific activity of GTP-cyclohydrolase was decreased by the addition 
of either dimethyl-8-ribityllumazine or hydroxymethylpteridine to the 
growth medium. The decrease in specific activity could be partially 
Table 11. The specific activity of GTP-cyclohydrolase after growth in the 
presence of and the subsequent removal of either 6,7-dimethy1-
8-ribityllumazine (DI-IRL) or 2-amino-^-hydroxy-6-hydroxymethyl-
pteridine (HMPt). 
Additions to the Specific Activity 
Growth I-fedium nmoles of formate released/mg protein/ml/hr 
Inoculated from Synthetic Inoculated from Supplemented 
into Supplemented Medium I»fedium into Synthetic I&dium 
Crude Heat Treated Crude Heat Treated 
None (control) 5.520 60.70 5.35 58.7 
DMRL 0.770 0.669 U.25 2%.3 
HMPt 0.917 0.76U U.83 26.2 
+ miPt 0.5^8 0.422 4.07 20.8 
Biotin (control) 0.274 0.131 O.865 7.23 
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reversed by the removal of the affectors. The decrease in the specific 
activity in response to the affectors could be caused either by a reduced 
number of enzyme molecules per cell or by a reduced activity of the enzyme. 
It has been observed that heat treatment of crude cell-free extracts 
consistently increases the specific activity of GTP-cyclohydrolase. It is 
unclear whether the heat treatment releases a tightly bound inhibitor, 
disassembles the protein complex of GTP-cyclohydrolase into sub-units or 
simply appears to increase due to the precipitation of heat labile protein. 
Regardless of how the heat treatment functions, the important feature 
is that the heat treatment of GTP-cyclohydrolase in the presence of 
affectors such as dimethyl-8-ribity.1.1 umazine, hydroxymethylpteridine or 
biotin actually decreases the specific activity. When the affectors are 
removed or diluted, the activation of GTP-cyclohydrolase by heat is 
partially restored. 
Attençts to demonstrate feedback inhibition of GTP-cycl<±iydrolase were 
inconclusive. There was a slight decrease (about 20^ to 30^) in the 
specific activity of the partially purified enzyme from the first peak of 
the Sephadex G-75 column when neopterin, hydroxymethylpteridine, hydroxy-
methyldihydropteridine, pteroic acid, rhizopterin, folic acid, dihydrofolic 
acid, dimethyl-8-ribityllumazine, riboflavin or FM were added individually 
to the reaction mixture. Similar results were obtained when ATP, inosine, 
thymine, thymidine, serine or methionine were added, A more pronounced 
decrease in the specific activity (about 80^) was observed when biotin was 
added to the reaction mixture. It is not known whether biotin inhibits 
the reaction or simply binds the one carbon unit released from GTP thus 
giving a deceptive appearance that the reaction was inhibited. lyridoxal-
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6-phosphate, which stimulates both folate and riboflavin synthesis in 
cultures, had no effect upon the release of formate from GTP in the reaction 
mixture. It was believed that pyridoxal-6-phosphate may participate in the 
purine ring-opening reaction by forming a Shiff's base. Since only one 
concentration of substrate and one concentration of affector was used in 
all of these experiments, nothing conclusive can be said about feedback 
inhibition of GTP-cyclohydrolase. If GTP-cyclohydrolase is subject to 
negative feedback inhibition, then the most probable inhibitor would be the 
compound just prior to the hypothetical branch point in the pteridine 
pathway. 
The lt,5-diaminopyrimidine type compounds are presumed to be the 
intermediates arising from GTP for both riboflavin synthesis (5) and folate 
synthesis (129). The isolation of such a hypothetical intermediate followed 
by the enzymatic synthesis of both folates.and riboflavin from it would 
provide the direct evidence for a branched pteridine pathway. Furthermore, 
the regulatory role of such a compound could then be thoroughly examined. 
Because of the reported instability of these types of compounds and the 
lack of an adequate method to follow their formation, the presence of such 
compounds could only be inrolied. 
The supernatant from five 0.5-ml reactions of r with the 
partially purified GTP-cyclohydrolase were pooled. Jhe substrate and 
intermediates were adsorbed onto activated charcoal and the radioactive 
formate was removed by filtration. The substrate and intermediates were 
eluted from the charcoal with a solution of 95^ ethanol:concentrated NH^OH 
(3:1, v/v) and dried in a vacuum oven at 60 C. The residue was resuspended 
in 2.5 ml of deionized water and added to a column (0.7 X 20 cm) of DEAE 
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cellulose. The column was washed with 50 ml of water and then eluted in a 
stepwise fashion with 50-ml portions of 0.05 W, 0.1 M, 0.2 M and 0.5 M 
ammonium acetate. The eluent was collected in 5~ral fractions and each 
fraction was exaicined for radioactivity and UV absorption at 230, 2^0, 250, 
260 and 280 nm. If there was any UV absorption at any of the fixed wave­
lengths, then an absorption spectrum was determined for that sample. Four 
radioactive compounds were eluted from the DSAE cellulose column with the 
following molarities of ammonium acetate; Compound I, 0.05 M; Compound II, 
0.2 M; Compound III, 0.2 M; and Compound IV, 0.5 M. Table 12 shows some 
characteristics of each compound. Compound IV was identified as GTP on the 
basis of its UV absorption spectrum, its in Solvent A and Solvent B, and 
Table 12. The characteristics of the compounds eluted from DSAE cellulose 
vhich originated from GTP-8-^ C incubated with partially 
puridied GTP-cyclohydrolase. 
Compound Molarity of Radioactivity R_ value of Radioactive UV Absorption 
Eluant CPixI Compounds in 0.1 II NaOH 
Solvent A Solvent B Ab _ Ab_._ max mill 
Formate®' _b 21,200 - - -
-
Compound I 0,05 62,600 0.36 0.1k 265 235 
Compound II 0.2 7,800 - 0.46 258 232 
Compound III 0.2 1,300 - 0.09 2U5 230 
Coinpound IV 0.5 675,800 0.90 0.03 258 
265 
230 
GTP Standard 0.5 — 0.93 0.01 258 
265 
230 
®Determined by Celite chromatography, 
^ot determined. 
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the similarity of its e lut ion pattern from DEAE cellulose compared with 
authentic GTP, Couroound I and Compound II have UV absorption spectra that 
are characteristic of pyrimidine confounds in general and Compound I has 
a UV spectrum (Fig. 8) which is very similiar to the reported UV spectrum 
for a formamido pyrimidine congound synthesized non-enzymatically from 
GTP (107)• The radioactive carbon atom on Coinpound I (originating from C-8 
of GTP) is labile in 2 IÎ H2S0^^ and is released in the form of formic acid. 
Either 2,U,5-triajnino-6-hydroxypyrimidine or U,5-diamino-2,6-dihydroxy-
pyrimidine are known to react with glyoxal to form either 2-amino-U-hydroxy-
pteridine (pterin) or 2,6-dihydroxypteridine (lumazine) respectively (57). 
And 4 (l' -D-ribitylamino)-5-amino-2 ,G-dihydroxypyrimidine will react with 
diacetyl to form 6,7-dimethyl-8-( 1 *-D'ribitylamino)lumazine (6l, 88, 89, 
117» 126). In order to determine the nature of Compound I, it was reacted 
with diacetyl. The product was non-radioactive, had a yellow-green 
fluorescence under UV light (25^ nm) and had values of O.lS and 0.55 in 
Solvent B and Solvent C respectively. The condensation product stimulates 
the growth of a riboflavin-deficient mutant of Bac-Ltlus subtiZis, The 
riboflavin mutant of B, svibt-it-ls was isolated and characterized by H. R. 
Turner. Dimethyl-8-ribityllumazine was shoim to replace the riboflavin 
requirement. The condensation product of Compound I appears to be 
6,7-dimethyl-8-ribityllumazine. This suggests that Compound I is probably 
U-ribitylamino-5-formainido-2,6-dihydroxypyrimidine or a phosphate ester 
of such a compound and that C-8 of GTP is retained on N-5 of the pyrimidine 
intermediate until after both an oxidative deamination at C-2 of the 
pyrimidine and a rearrangement of the ribose moiety to a ribityl moiety. 
Compounds II and III could not be characterized except to note their 
Fig, 8 The UV absorption spectra of Compound I from DEAE cellulose in 0.1 N NaOH ( O ) ,  0.1 M 
potassium phosphate buffer, pHT.O ( •) and 0.1 N HCl (©). The inset lists the reported 
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UV absorption maxiinura and minimum upon the initial separation on the DEAE 
cellulose column. There vas a very small quantity of each and the radio­
active carbon of both compounds was acid labile. Within 2k hr after the 
separation of these compounds, the UV spectrum of each became indistinct 
with no sharp absorption maximum or minimum. 
Since Compound II and Compound III from the DEAE cellulose column were 
unstable and found in such small quantities, GTP-U-l^C was used as a sub­
strate so that the intermediates would have a radioactive label. After 
the enzymatic reaction was stopped, the mixture was reacted .with either 
glyoxal or diacetyl in order to make stable pteridine derivatives from any 
ij,5-diaminopyrimidines that were enzymatically formed. The mixture from 
the glyoxal condensation was added to a DEAE cellulose column. The column 
was washed with 50 ml of water and developed stepwise with 50 ml volumes 
of formic acid in increasing molarity (0.001 M, 0.005 H, 0.01 M, 0.05 M, 
0.1 M, and 1.0 M). A radioactive substance was eluted from the column in 
the first 20 ml of the 0.001 14 formic acid. The elution pattern from the 
column was identical to authentic pterin and the UV absorption spectrum 
was identical to authentic pterin. However, when the radioactive sarple 
was chromatographed on ^vhatman IIo. SI'®! paper in Solvent B, two compounds 
were found with values of 0.35 and 0.^6. Both compounds were radioactive, 
both had an ice blue fluorescence under UV light (25^ nm), and neither 
conroound would stimulate the growth of the riboflavinless mutant of B, 
subti-li-s, These compounds are assumed to be either a riboside or ribotide 
derivative of a pterin and a lumazine, but there are no authentic standards 
for comparison. 
Ifhen the enzymatic products from GTP-U-^^C are reacted with diacetyl 
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and chromatographed, there are two najor radioactive fluorescent confounds. 
One has an ice "blue fluorescence under UV light, an of 0.58 to 0.68 in 
Solvent C and will not stimulate the growth of the riboflavinless mutant 
of B. subt-Vl-ls. This conmound is "believed to be either a riboside or 
ribotide derivative of 6,7-diiaethylpterin, but there are no authentic 
standards for comparison. The other compound has yellow-green fluorescence 
under UV light, an of 0.51-0.57 in Solvent C and strongly stimulates the 
growth of the riboflavin mutant of S. subt'it'is. This compound is either 
6,7-dimethyl-8-ribityllumazine or a phosphate ester of such a compound. 
Table 13 summarizes the R^ values and the biological activity for 5. 
subt'it'is of the compounds formed from either a glyoxal or a diacetyl 
condensation. The radioactive pteridine-like compounds formed by a con­
densation with either glyoxal or diacetyl suggests that the ,5-diamino-
pyrimidine type compounds are intermediates in pteridine biosynthesis and 
that they originate from OTP. These pyrimidine intermediates are probably 
If-(l'-D-ribitylamino)-5-formamido-2,6-dihydroxypyrimidine and 2-amino-U-
(l'-D-ribosylamino)-5-formamido-6-hydroxypyrimidine or a phosphate ester 
of such compounds. These two intermediates would be expected if GEPwas 
the precursor of both folates and riboflavin and if the pteridine pathway 
vas branched or if there were isoenzymes of GTP-cyclohydrolase. 
70 
Table 13. The values and the biological activity for a riboflavinless 
mutant of 5. svht%L-ls for pteridine-like compounds formed from 
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This investigation has revealed two significant features about folate 
and riboflavin biosynthesis in Staphyloaoaous epidermi-dis, First, there is 
a change or an adjustment of both folate and riboflavin biosynthesis in 
response to the physiological changes that occur during growth in a given 
culture medium and in different culture media. Second, under all experi­
mental conditions that were used, S. epidermidis always synthesizes and 
excretes more folate or riboflavin than is required by the organism for 
growth. The first feature, the adjustment of biosynthesis in response to 
physiological changes, is important in making a distinction between 
constitutivity and an elaborate control mechanism where either the quantity 
or the activity of the biosynthetic enzymes change in response to the 
physiological environment. The extent of adjustment and the rate of 
adjustment of either folate or riboflavin biosynthesis helps to differentiate 
between an induction-repression mechanism and a feedback inhibition mecha­
nism. The second feature, overproduction, is a measure of the precision 
of adjustment. In describing a regulatory mechanism for folate or ribo­
flavin biosynthesis in S. epideTrrtidis  ^ both adjustment to physiological 
changes and overproduction must be considered. 
Adjustment of folate and riboflavin biosynthesis to physiological changes 
Pardee and Beckwith (82) imply that the enzymes responsible for the 
synthesis of minor metabolites are constitutive and have a constant and 
excessive rate of synthesis per organism. If the enzymes for the minor 
pathways are constitutive, then the following characteristics would be 
expected: the total synthesis of either folates or riboflavin (intracellular 
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plus excreted) would increase at a constant rate during grovrth and the 
concentration of vitamins would parallel growth; the total synthesis per 
cell per generation would be constant; the specific activity of an enzyme 
in the given pathways would be constant; and the vitamins would always be 
overproduced resulting in excretion of both folates and riboflavin. But, 
if the enzymes for the minor pathways have an elaborate control mechanism, 
then the total quantity of folates sad riboflavin should vary significantly 
in response to physiological changes ; "Ciie total synthesis per cell per 
generation should not be constant; the specific activity of GTP-cycldhydro-
lase, pteroate synthetase and riboflavin synthetase should vary during 
growth in different culture media; and the end product should not be 
overproduced. 
The rate of enzyme formation can vary by a factor of 1000 or more (19, 
38, 99) for some enzymes which are subject to induction-repression. But 
the rate of enzyme formation has been reported to vary from 10- to 30-fold 
for several enzymes of the uracil (9), tryptophan (130) and histidine (2) 
pathways. There is some uncertainty in determining whether an enzyme is 
truly constitutive or subject to induction-repression when the specific 
activity of an enzyme remains relatively constant under a variety of growth 
conditions (82). vThen differentiating between constitutivity and induction-
repression in systems where the rate of enzyme synthesis does not change 
dramatically, it is necessary to consider the total synthesis and the rate 
of synthesis as well as the specific activity of the enzymes. 
The data presented show that the total quantity of either folate or 
riboflavin synthesized by S. epi-demvCdi-s changes in response to physio­
logical changes. The concentration of folic acid-like compounds varies 
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from about 15 ng/ml ( 0.008 nmole/mg diy veight) for organisms grown in the 
biotin-supplemented medium to about 500 ng/ml (2,2 nmoles/mg dry veight) 
for organisms grown in the synthetic medium. In addition to changes in 
nutrition, if the aeration is also changed, the concentration of folates 
synthesized ranges from less than 0,1 ng/ml to about 8000 ng/ml. The 
concentration of total riboflavin synthesized usually ranges from about 5 
ng/ml (0.01 nmole/mg dry weight) for organisms grown in the biotin-
supplemented medium to about 2500 ng/ml (3,7 nmoles/mg dry weight) for 
organisms grown in the FAAM, 
Even thou^ the total synthesis varies considerably both during growth 
and in different physical and nutritional environments, the intracellular 
concentrations of both folate and riboflavin always remain constant during 
exponential growth. Although remedning constant during growth, the intrar-
cellular concentrations do change with the nutritional composition of the 
medium. The intracellular concentraticai of folates varies from 0,0009 nmole/ 
mg dry weight for organisms grown in the biotin-supplemented medium to 
0.012 nmole/mg dry weight for organisms grown in the synthetic medium. 
The intracellular concentration of riboflavin varies from 0.018 nmole/mg 
dry weight in the biotin-supplemented medium to 0,45 nmole/mg dry weight 
for organisms grown in the FAAM, Assuming that S, epidermidis has hO% 
protein/mg dry weight, then the intracellular concentration of riboflavin 
ranges from 0,045 vanole/g protein to 1,1 iJmoles/g protein depending upon 
the growth medium, compared to a constant intracellular concentration of 
riboflavin of 0,27 vmole/g protein as reported for E, aoli (125), The 
constant intracellular concentration of either folate or riboflavin 
probably represents the physiological requirements of 5, epidepmidis 
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needed to maintain the maximuDi growth rate in a specific medium. When the 
"biosynthesis of either folate or riboflavin exceeds the quantity required 
for growth, the excess is excreted into the culture medium. 
The excreted folates and riboflavin do not increase at a constant rate 
during growth. Instead, there appears to be a loss of the excreted folates 
during the exponential growth phase. The apparent loss of folates is 
deceptive. I believe this is nothing more than the formation of conjugated 
pteridines which have different dose responses for 5, faeoati-s. It was 
shown that the tjijes of folic acid-like compounds found in the spent 
culture medium shift in relative concentration to one another depending 
upon the phase of growth. Some types of folic acid-like compounds are 
found in the spent culture medium of only young cultures while others are 
found only in the stationary phase cultures. Most of these biologically 
active derivatives are not present in large enough quantities to determine 
their dose response for S, faeoatis» This explanation is plausible since 
the dose responses for the oxidized and reduced pteroic and folic acids 
are different in S. faecaZz-s, Thus, it is probable that there are still 
the same number of molecules of the basic conjugated pteridine but they 
have been altered to a less active form. 
The compounds that stimulate either folate or riboflavin synthesis 
may participate in the synthesis of these vitamins. Some examples: pABA is 
coupled to pteridines to make pteroates; xanthine or inosine could be 
changed intracellularly to a precursor of both the folates and riboflavin; 
pyridoxine could participate in the purine ring-opening reaction by 
forming a Shiff*s base; 2,1*,5-triamino-6-hydroxypyrimidine and uracil are 
structurally siniliar to the proposed pj.'rimidine moiety of the folate and 
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riboflavin intermediates ; and citrate may function in the synthesis of the 
ll-carhon donor that forms the lumazine ring system in riboflavin synthesis. 
With the exception of the role of pABA, the other explanations are hypo­
thetical. All the compounds which stimulate folate or riboflavin synthesis 
also inhibit the growth of the organism. The more that growth is inhibited, 
the greater the relative synthesis per mg dry weight. The reverse also 
seems to be true, that any change in the nutritional environment that 
stimulates growth of the organism also decreases the relative synthesis 
of both the folates and riboflavin. Thus, when biotin is added to the 
synthetic medium, the length of the lag period is reduced, the generation 
time is reduced, the maximum population is nearly triple that for the 
synthetic medium alone, the folate synthesis per mg dry weight is reduced 
50-fold and the riboflavin synthesis per mg dry weight is reduced 10-fold. 
Biotin not only decreases folate synthesis and stimulates growth, but it 
also decreases the intracellular concentration of folates about 15-fold. 
It is possible that the biotin interaction in some way partially replaces 
the function of folic acid, therefore, it decreases the requirement for 
folate synthesis. However, the general phenomenon of good growth-low 
folate and riboflavin synthesis suggests that an inhibitor is produced in 
large quantities when the organism is growing rapidly, resulting in decreased 
folate and riboflavin synthesis. 
The rate of synthesis during exponentiail growth of a culture can be 
calculated from the formula: 
where R^g is the rate of vitamin synthesis, [Vjg is the total vitamin 
content of the culture (intracellular + excreted) at the end of the incuba­
tion period, [V]^ is the total vitamin content at the beginning of the 
incbation period, is the bacterial mass at the end of the incubation, 
Mj_ is the mass at the beginning of the incubation and y is the specific 
growth rate (13). A negative value indicates that growth exceeds vitamin 
synthesis resulting in a decrease in the vitamin concentration per cell per 
unit time. Under all experimental conditions the rate of synthesis of 
either the folates or riboflavin have negative values during exponential 
growth. This indicates that the growth rate exceeds the rate of folate or 
riboflavin biosynthesis during exponential growth. This is in direct 
conflict with reports of a constant positive rate of flavin biosynthesis 
during exponential growtn in E, coZi (125) and in C, qut-Zliermodii (95). 
There is a positive rate of synthesis during the lag phase and during the 
transition phases of accelerated and decelerated exponential growth. 
Neither Wilson and Pardee (125) nor Shavlovskii and Strugovshchikova (95) 
examined flavin synthesis in the lag or accelerated exponential phases 
of growth. Both groups of investigators resuspended exponentially-growing 
cultures into fresh medium and then exanined the rate of synthesis. 
When S, epi-dermidis is grown under different physiological stresses, 
the total synthesis and the rate of synthesis of the folates and riboflavin 
should be a reflection of the enzymatic activity of the respective path­
ways. Since the growth medium can be manipulated in a way to force S, 
epidermidi-s to synthesize different quantities of folates and riboflavin 
relative to each other, the specific activities of the enzymes from the 
pteridine, folate and riboflavin pathways should also change relative to 
one another, I wanted to compare the activity of an enzyme to the total 
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synthesis of either the folates or riboflavin; therefore, crude cell-free 
extracts were used as a source of the en^nnes. 
There are two limitations related to the use of crude extracts. First, 
the crude extracts contain substrates, intermediates, end products and 
potential inhibitors, all of which interfere with the enzyme assays. 
Usually these snail molecules are removed by dialysis, but the crude extracts 
could not be dialyzed because 99^ of the pteroate synthetase activity is 
lost by dialysis. And second, a change in the specific activity of an 
enzyme from different extracts could be due to either a change in the 
quantity of the enzyme (induction-repression) or a change in the activity 
of the enzyme (feedback inhibition). IThen comparing enzymes prepared from 
organisms grown in different culture media, this could be a real problem. 
The specific activities of GTP-cyclohydrolase, pteroate synthetase and 
riboflavin synthetase decrease about 16-, 29- and 2-fold respectively when 
the synthetic culture medium is supplemented with biotin. But, when the 
activity of an enzyme is compared during growth, the rate at which the 
specific activity decreases distinguishes between repression and feedback 
inhibition. With feedback inhibition the enzyme activity would decrease 
abruptly, whereas with repression the decrease would be slow as the enzymes 
are diluted with cell division. The loss of specific activity can be 
greater than predicted for dilution alone if the enzyme is not only 
repressed, but is also being degraded. During early exponential growth in 
the synthetic medium, the specific activities of GTP-cyclohydrolase, 
pteroate synthetase and riboflavin synthetase decrease about 15-, 8- and 
8-fold respectively. Both pteroate synthetase and riboflavin synthetase 
lose about one half of their specific activity per generation which 
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indicates that the enzymes are being diluted, GTP-cyclohydrolase loses 
more than half of its activity during the second generation of early 
eopcaiential growth in synthetic medium; however, the loss during the first 
generation (about 50? of the enzyme activity 
During exponential growth, GTP-cyclohydrolase, pteroate synthetase 
and riboflavin synthetase are repressed. If some of the end products of 
folate metabolism (thymine, thymidine, serine, glycine and methionine) 
are added to the growing culture, the pteroate synthetase activity does 
not increase, suggesting that the end products of folate metabolism 
repress the folate pathway. The addition of these compounds has no 
effect upon riboflavin synthetase activity. GTP-cyclohydrolase activity is 
not required for the synthesis of the folate pteridines since the pteroate 
synthetase is repressed, yet, GTP-cyclohydrolase is only partially 
inhibited by the end products of folate metabolism. Apparently another 
product of GTP-cyclohydrolase is required, possibly for riboflavin syn­
thesis. Biotin also inhibits pteroate synthetase, has little effect upon 
riboflavin synthetase and partially inhibits GTP-cyclohydrolase, again 
suggesting that GTP-cyclohydrolase functions in both folate and riboflavin 
biosyntheses. This hypothesis is strengthened by the fact that both 
dimethyl-8-ribityllumazine, an intermediate in riboflavin biosynthesis, 
and hydroxymethylpteridine, an intermediate in folate biosynthesis, 
decrease the specific activity of GTP-cyclohydrolase vhen added inde­
pendently and in combination to the culture medium. 
On the basis of growth, excreticai, rates of synthesis and specific 
activities of the enzymes from the pteridine, folate and riboflavin 
pathways, I can only conclude that the enzymes of both folate and 
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riboflavin biosynthetic pathways are not constitutive. Both pathways 
appear to have an elaborate control mechanism. The only feature that is 
inconsistent with an elaborate control mechanism is that under all 
experimental conditions S» epidernridis overproduces and excretes both 
folates and riboflavin. 
Precision of adjustment. 
The excretion of a biosynthetic end product signifies that the 
control mechanisms in the pathway are not precise enough to prevent the 
compound from being overproduced (27» 7^» 125). Therefore, one criterion 
for the precision with which a biosynthetic pathway is controlled is the 
extent of overproduction. Wilson and Pardee (125) suggest that the ratio 
of excreted product to intracelliilar product (E/I ratio) should be a 
measure of the weakness of a control mechanism. They report that the 
E/I ratio of flavin production in E, coZi ranges from 0.8 to 8.0 compared 
to about 0.05 for the nucleic-acid bases. Yet the absolute quantity 
of flavins that are excreted is no greater than the absolute quantity of 
amino acids or nucleic-acid bases that are excreted into the culture 
medium. This raises an interesting question. For a biosynthetic pathway 
that is fully repressed and under the influence of a feedback inhibition 
mechanism, how many moles of product are formed, if any? I don't know of 
any reports in the literature that state that feedback inhibition is an 
absolute inhibition of an enzyme. Bacteria that have inducible biosyn­
thetic pathways still synthesize the enzymes in the absence of an inducer. 
Khogness (48) reports that when 3-galactosidase is completely repressed 
and there is an absence of inducer in the medium, E. colt forms about 20 
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active $-galactosidase molecules per cell. This is hy far more enzyme 
molecules than Mcllwain (63) postulates are present for enzymes of any 
vitamin "biosynthetic pathway. 
The E/I ratio for either the folates or riboflavin in S, epz-derirtidis 
varies greatly depending upon the phase of growth or the nutritional 
supplementation. During the lag and accelerated exponential phases of 
gro»-fch the E/I ratio is several hundred . The lowest E/I ratio for the 
folates (about 2.1) occurs during the mid-exponential growth. For ribo­
flavin , the lowest E/I ratio (about 0.5) occurs in the early stationary 
phase of growth. Thus, neither the folate nor the riboflavin pathway has 
a very precise regulation when examined on the basis of overproduction. 
It is not surprising that 5. epz-dermidi-s does not have a precise 
regulatory mechanism for the biosynthesis of folic acid-like compounds. 
5. epidermidiSf like most organisms used to study the biosynthesis of 
vitamins, was originally selected because it excreted large quantities of 
folic acid-like compounds. Investigators have either consciously or 
unconsciously selected organisms which excrete large quantities of the 
vitamin in question because the enzymes for the specific pathway should 
be present in a higher quantity or in a more active form in such an 
organism. Therefore, the intermediate conroounds as well as the end 
product should be produced in relatively high quantities and the biochemi­
cal pathway should be easier to elucidate. These same organisms, specifi­
cally E, ootzrj L, ptanixzrum and S. epidermid-is in which the folic acid 
pathway has been determined to various degrees, are now being studied in 
attempts to demonstrate the mechanism of regulation. Since all of these 
organisms overproduce folic acid-like compounds, it is unlikely that they 
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are subject to exact regulation. Therefore, feedback inhibition, if it 
exists in this type of organism, must play a minor role in the overall 
regulation of folate biosynthesis. I unsuccessfully tried to find either 
mutants or strains of S» epidermidis which would not excrete folic acid­
like compounds thinking that such an organism would be subject to exact 
regulation. However, I found one strain of B, subtitus and three isolates 
of Aainetobaster which excreted no detectable folic acid-like coinpounds. 
None of these organisms was examined in detail. 
I was unable to find any folate auxotrophs of S, epi-dermidi-s. No 
folate auxotrophs have been found in E, coti- (G. M. Brown, Massachusetts 
Institute of Technology, Cambridge, personal communication) or in L, 
pZantamm (T. Shiota, University of Alabama Medical Center, Birmingham, 
personal communication). It was simple and attractive to explain the 
lack of folate auxotrophic mutants on the basis that the organism did not 
have a transport mechanism to get folic acid into the cell, therefore, 
the mutation was lethal. It is clear that folic acid can enter the cell 
since radioactive folic acid was found inside S, epidermidis when grown 
in the presence of exogenous radioactive folic acid. It is possible that 
a mutation in the folate pathway may also alter the permeability for 
folic acid, but currently there is no experimental evidence to 
support this hypothesis. Without folate auxotrophic mutants it was 
inroossible to get double mutants requiring both folate and riboflavin 
for further biochemical and genetic studies. 
If only the E/I ratio is considered, then 5, epidevmidis is not 
precisely regulated. However, the total quantity of excreted folates or 
riboflavin is no greater than the reported quantity of purine or 
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pyrimidines that are excreted. From this point of view, the regulatory 
mechanism for the folates or riboflavin is as precise as the regulatory 
mechanisms for the major "biosynthetic pathways, 
A branched pteridine "biosynthetic pathway 
Purines can serve as a precursor for "both folate and riboflavin 
biosynthesis with the expulsion of C-8 of the purine (l8, 23, 35, 56, 57, 
58, 69, 70, 93, 102, 108). GTP has been established as the purine 
precursor of the folate pteridines (18, 23, 56, 57, 58, 102, IO8) and 
guanine, or a nucleoside or nucleotide derivative of guanine, has been 
established as the purine precursor for riboflavin biosynthesis (U, 7, 35, 
37). Both folic acid-like compounds and riboflavin are synthesized by S. 
epidevmidis\ thus, it is probable that the two pathways share a common 
precursor and have some common intermediates. GTP-cyclohydrolase is a 
large enzyme complex which catalyzes the elimination of C-8 of GTP in the 
synthesis of the folate pteridines and isomerizes the ribose moiety to a 
l*-deoxy-2*-keto pentose unit by an Amadori rearrangement. I believe that 
some of the intermediates formed by the GTP-cyclohydrolase complex in the 
formation of the folate pteridines are also intermediates in riboflavin 
biosynthesis. 
The Amadori rearrangement is an example of acid-base catalysis (36). 
It is necessary that the N-substituted ribosylamine be sufficiently basic 
to accept a proton. The Amadori rearrangement proceeds in three steps: 
1) the acceptance of a proton by the ribosylamine base; 2) a prototrophic 
shift; and 3) the discharge of a proton from the cation originally formed. 
Fig. 9 shows the mechanism of the Amadori rearrangement and the hypo-
Fig, 9, A hypothetical scheme for a branched pteridine biosynthetic pathway. 
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the tic al "branch point in the pteridine pathway. During the Amadori 
rearrangement, there is an initial attack by a proton on the nitrogen 
forming an ammonium ion (Compound III) which is in equilibrium with the 
cation of a Schiff's base (Compound IV). A shift of the double bond and a 
flow of electrons toward the positive nitrogen atom makes C-1' transiently 
positive. A second flow of electrons from C-2* to C-1' weakens the C-H 
bond on C-2*, causing the expulsion of that proton to give the enol form 
(Compound V) of the ketose derivative (Compound VI). The tautomeric shift 
to the keto form (Compound VI) is driven by the tendency of Compound VI 
to form a stable ring. 
Primary amines readily react with a carbonyl group while secondary 
amines react slowly or not at all if sterically hindered. Based upon the 
reactivity of primary amines and secondary amines with carbonyl groups, I 
propose that the initial enzymatic hydrolysis of the imidazole ring of 
GTP must cleave the ring between C-8 and N-9 of OTP leaving a formyl group 
attached at what was formerly Iî-7 of GTP, resulting in the formation of 
2-araino-U-( I'-D-ribosylaminotriphosphate )- 5-f onmmi do-6-hydr oxypyr imi dine 
(Compound II). Shiota (103) has shown the 5-formmidopyrimidine structure 
to be correct and a stable derivative. If the initial hydrolysis was 
between ÏÏ-7 and C-8 of GTP, then what was formerly N-7 of the purine 
would become a primary amine and would readily react with the fornyl group 
to make GTP, 
I propose that compound V is the branch point in the pteridine path­
way and this compound leads to the synthesis of both folic acid-like 
confounds and riboflavin. A reduction of compound V would result in the 
formation of a 2-amino-lt-(l'-D-ribitylamino)-5-formamido-6-hydroxypyrimi-
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dine (Conçound VII) or a phosphate ester thereof which can be oxidatively 
deaminated at the C-2 position of the pyrimidine forming a U-(l'-D-ribityl-
aznino)-5-formamido-2,6-dibydroxypyrimidine derivative (Couçound VIII), 
Both 2,5-diamino-li(l'-D-ribitylamino)-6-hydroxypyTimidine (3, 5» 6, 76) 
and l»-(l*-D-ribitylamino)-5-ajnino-2,6-dihydroxypyrimidine have been shown 
to be accmmilated by riboflavin mutants of 5, ceTivisiae and A* niduZans, 
The reason that I believe that the intermediates retain the original 
C-8 of GTP as a formyl group is : first, the electron withdrawing properties 
of the formyl group attached to the nitrogen would prevent a nucleophillic 
attack upon a carbonyl group of the Amadori rearrangement products until 
after the first true riboflavin intermediate was formed; and second, the 
pyrimidine-like intermediates formed from GTP-8-^^C are radioactive. The 
radioactive carbon is acid labile and is released as formic acid. One of 
these intermediates can be condensed with diacetyl yielding radioactive 
formic acid and a pteridine compound which resembles 6,7-dimethyl-8-ribityl-
lumazine. Another radioactive intermediate forms a 6,7-dimsthylpterin 
derivative when condensed with di acetyl. 
Other supporting evidence for a branched pteridine biosynthetic path­
way is: first, cultures grown in the presence of 6,7-dimethyl-8-ribityl-
lumazine have a very low GTP-cyclohydrolase activity compared to cultures 
grown in the absence of é,T-dimethyl-8-ribityllumazine; second, the GTP-
cyclolydrolase activity is partially restored when 6,7-dimethyl-8-ribityl-
lumazine is removed; and finally, GTP-cyclohydrolase activity changes with 
the same relative proportion as riboflavin synthetase activity and with no 
change in the pteroate synthetase activity. 
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Regulation of folate and riboflavin biosynthesis 
Pardee and Beckwith (82) point out that the rate of synthesis of some 
repressed enzymes is hundreds or thousands of times greater than the rate 
of synthesis of other repressed enzymes. Yet, several investigators (63, 
8l, 82, 95» 125) have emphasized the low rate of vitamin and coenzyme 
synthesis compared to the rate of synthesis of the major metabolites. 
They have asked what prevents vitamins from being synthesized at the same 
rate as amino acids, purines or pyrimidines, only to conclude that there 
must be one or a very few molecules of the vitamin biosynthetic enzymes 
per cell. These same investigators have not questioned the mechanism 
which prevents the major metabolic pathways from functioning at the same 
rate as the catabolic pathways for a primary carbon source. This is the 
same question1 These two mechanisms must be similar, simple, able to 
withstand evolutionary selection and in essence a function of the genetic 
code. 
Ihe regulation of the enzymes of the catabolic and the major metabolic 
pathways is defined in terms of constitutivity, induction-repression and 
negative feedback inhibition. The constitutive enzymes are produced at 
a relatively constant rate independent of nutritional conditions. In 
contrast to the constitutive enzymes, the enzymes subject to induction-
repression are synthesized at different rates depending upon the nutritional 
conditions. Finally, negative feedback inhibition controls the activity 
of engines already synthesized. 
The adjustment of folate and riboflavin biosynthesis in response to 
nutritional changes can be explained by induction-repression. With the 
exception of overproduction, the criteria for an induction-repression 
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mechanism have "been demonstrated. The riboflavin synthetase enzyme appears 
to "be constitutive "based upon the negligible change in the specific 
activity in response to changes in nutrition. But the change in total 
riboflavin synthesis in response to nutritional changes indicate that the 
pathway is subject to induction-repression. 
It is difficult to evaluate the role of negative feedback inhibition, 
especially since GTP-cyclohydrolase and pteroate synthetase are enzyme 
complexes which catalyze more that one reaction, I believe that a weak, 
sequential feedback mechanism does function in the folate biosynthetic 
pathway. It appears as if the products of folate metabolism do feedback 
inhibit the pteroate synthetase. I suspect that the purine ring-opened 
intermediate feedback inhibits the initial hydrolytic reaction in the 
GTP-cyclohydrolase complex. Based upon overproduction and excretion of 
folates and riboflavin, feedback inhibition does not play a significant 
regulatory role in the biosynthesis of folates and riboflavin in S, 
ep-idernridis, The lack of a precise regulatory mechanism should be expected 
in Sm ep'tdenrridis because the organism was originally selected on the basis 
of the large quantities of folic acid-like conroounds which it excretes. 
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SUI-fl.IARY 
Folate and riboflavin bi©syntheses appear to be regulated by an 
induction-repression mechsmism. There is rapid synthesis of both vitamins 
during lag and accelerated exponential growth; synthesis stops or is 
severly reduced during exponential growth; and synthesis is again initiated 
during decelerated exponentisil growth. Both folate and riboflavin 
biosyn theses are reduced when the culture medium is supplemented with 
biotin; and the syntheses of both are partially restored when the biotin 
is then removed from the culture medium. Purines, pyrimidines, citrate 
and-pyridoxine stimulate folate and riboflavin biosyn the ses, but all these 
compounds also inhibit growth of S, epidermidis, Under all experimental 
conditions, 5, ep'idermidi.s overproduces and excretes both folates and 
riboflavin. 
Bae activity of GTP-cyclohydrolase is inhibited when S, epi.demn.dis 
is grown in the presence of 6,7-dimethyl-8-ribityllumazine, hydroxymethyl-
pteridine or biotin; the activity is partially restored when these 
compounds are subsequently removed from the culture medium, Pteroate 
synthetase is inhibited when the products of folate metabolism (thymine, 
thymidine, serine, glycine and methionine) are supplemented into the 
culture medium. Riboflavin synthetase appears to be constitutive, 
GTP-cyclohydrolase seems to function in the syntheses, of both folate 
and riboflavin pteridines, suggestion a branched pteridine pathway. 
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Spherical to ovoid cells, 0.5 to 1.5 microns in 
diameter. Non-motile. Occurring in singles, 
pairs, tetrads and clusters. Gram positive. 
Convex, glistening, entire margin, 1 mm in 
diameter. 
%ite. Becomes browish-yellov within 1*8 hr when 
exposed to light at room temperature. 
Heavy growth. At first turbid, later clear with 
mucoid sidinent. 
Heavy growth, white, smooth, glistening, viscous. 
Positive. 
Positive. 
Acid in 2k hr. Coagulated in U8 hr. 
Facultative anaerobe. 
Negative. 
Positive in US hr. 






Sensitive to lysostaphin. Resistant to lysozyme 










Fermentative. Acid from glucose, lactose, sucrose. 




Niacin, Niacin and thiamine are required when 
pyruvate is the primary carbon source. 
Many. Growth in the absence of glycine, serine, 
alanine, methionine, histidine, tyrosine, 
phenylalanine. 
31 mole per cent G + C (buoyant density). 
Slight growth at 10 C. Moderate growth at 4$ C. 
Optimum at 35 C. 
Fig. Al. The relationship of optical density to dry weight. Corrected 
optical density for growth in synthetic medium (•); corrected 
optical density for growth in FAAi-l ( Q) » Uncorrected optical 
density for growth in FAAM (A); optical density for growth in 
FAAM, 1:5 dilution after 0D=1.0 (A) [see Growth determinations, 
EXPERIMENTAL PEOCSDURE]. 
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Table A2. values and biological activity for standard compounds. 
Compound Solvent System Biological Activity 
A B C S, faeaatis L, aasei. 
GTP 0.93 0.01 0.16 0^ 0 
GDP 0.89 0.05 0 0 
Glvî? 0.85 0.11 — 0 0 
Z-Neopterin 0.68 0.18 — 0 0 
d-Neopterin 0.67 0.20 - 0 0 
Pterin 0.58 0.37 0.48 0 0 
6,7-dime thyIpte rin 0.57 0,k6 0.62 0 0 
Pteridine-6-COOH 0.51 0.15 0.23 0 0 
Pteridine-G-CHgO^ 0.58 0.27 0.40 0 0 
Xanthopterin 0.39 0.32 0.29 0 0 
Isoxanthopterin 0.1t5 0.22 0.30 0 0 
Lumazine - 0.1(1 0.50 0 0 
6,7-dimethyl-8-ribityl-
lumazine 0.74 0.21 0.49 0 0 
Riboflavin 0.36 O.5I+ 0.53 0 +++ 
FM 0. 56 O.lU 0.25 0 +++ 
FAD 0.1^5 0.06 — 0 +++ 
Folate 0.35 — — +++ +++ 
Dihydrofolate 0.17 — - +++ +++ 
K^O-f ormylfolate - - - +++ +++ 
Pteroate 0.01 — — +++ 0 
Rhizopterin 0.62 0.56 - +++ 0 
Pteroyl-Y-triglutamate - - - 0 +++ 
Pteroyl-Y-heptaglutamate i — 0 0 
®-Mot biologically active, 
^ot determined. 
Fig. A2. The elution profile from Celite 535 showing radioactive formic 
acid releases from GTP-8-l^C (0.3 ml^I, 5.2 X. 10^ DPM) hy GTP-
cyclohydrolase from different preparations: crude extracts (©); 
heat-treated crude extracts (O); partially purified extracts, 
Sephadex G-75» Peak I (•); partially purified extracts, Sephadex 
G-T5» Peak II or Peak III (Â). The inset is the elution profile 
of authentic ^^C-formic acid [see Purification of GUP-cyclo-
hydrolase, EXPERIMEIiTAL PEOCEDURE]. 
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Fig. A3. Growth curves in synthetic medium for S, epidermidis strain W, 
mutant NFA, mutant lîFB and eight strains from NADL: A-2; A-5; 
A-110; A-197; A-21:1; A-283; A-285; and A-286. 
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Table A3. A comparison, of growth and folate excretion in stationary and 
shake flasks "by strains of 5. epi-derrrCdis grown in synthetic 
medium. 
Strain Aerated Non-aerated 
Growth Folate equivalents Growth Folate equivalents 
OD^ ng/ml ODg ng/ml 
W 3.0 210 0.T2 26 
A-2 3.U 185 0.89 43 
A-5 3.2 19U 0.85 50 
HFA 2.6 136 0.80 18 
NFB 2.5 120 0.59 hk 
A-285 2.6 125 0.U5 2 
A-2 111 1.0 6h 0.84 45 
A-286 0.3 3h 0.33 k 
A-283 0.2 17 0.19 5 
Table Alt. The values in Solvent A of the excreted folates by strains 




0.25 O.Jt5 0.57 
W + + +++ ++++ 
A-2 + +++ — ++ ++++ 
A-5 + ++ — ++ ++++ 
UFA + ++ — +++ ++++ 
HFB + ++ +++ ++ ++++ 
A-285 ++ ± + + + 
A-2UI ++ ± ± ± 
A-286 + 
